Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 24
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Analysis of structural brain asymmetries in attention-deficit/hyperactivity disorder in 39 datasets

  • Postema, Merel C.
  • Vilarroya, Óscar
  • Francks, Clyde
Objective: Some studies have suggested alterations of structural brain asymmetry in attention-deficit/hyperactivity disorder (ADHD), but findings have been contradictory and based on small samples. Here, we performed the largest ever analysis of brain left-right asymmetry in ADHD, using 39 datasets of the ENIGMA consortium. Methods: We analyzed asymmetry of subcortical and cerebral cortical structures in up to 1,933 people with ADHD and 1,829 unaffected controls. Asymmetry Indexes (AIs) were calculated per participant for each bilaterally paired measure, and linear mixed effects modeling was applied separately in children, adolescents, adults, and the total sample, to test exhaustively for potential associations of ADHD with structural brain asymmetries. Results: There was no evidence for altered caudate nucleus asymmetry in ADHD, in contrast to prior literature. In children, there was less rightward asymmetry of the total hemispheric surface area compared to controls (t = 2.1, p = .04). Lower rightward asymmetry of medial orbitofrontal cortex surface area in ADHD (t = 2.7, p = .01) was similar to a recent finding for autism spectrum disorder. There were also some differences in cortical thickness asymmetry across age groups. In adults with ADHD, globus pallidus asymmetry was altered compared to those without ADHD. However, all effects were small (Cohen's d from -0.18 to 0.18) and would not survive study-wide correction for multiple testing. Conclusion: Prior studies of altered structural brain asymmetry in ADHD were likely underpowered to detect the small effects reported here. Altered structural asymmetry is unlikely to provide a useful biomarker for ADHD, but may provide neurobiological insights into the trait.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Consortium neuroscience of attention deficit/hyperactivity disorder and autism spectrum disorder: the ENIGMA adventure

  • Hoogman, Martine
  • Vilarroya, Óscar
  • Franke, Barbara
Neuroimaging has been extensively used to study brain structure and function in individuals with attention deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) over the past decades. Two of the main shortcomings of the neuroimaging literature of these disorders are the small sample sizes employed and the heterogeneity of methods used. In 2013 and 2014, the ENIGMA-ADHD and ENIGMA-ASD working groups were respectively, founded with a common goal to address these limitations. Here, we provide a narrative review of the thus far completed and still ongoing projects of these working groups. Due to an implicitly hierarchical psychiatric diagnostic classification system, the fields of ADHD and ASD have developed largely in isolation, despite the considerable overlap in the occurrence of the disorders. The collaboration between the ENIGMA-ADHD and -ASD working groups seeks to bring the neuroimaging efforts of the two disorders closer together. The outcomes of case-control studies of subcortical and cortical structures showed that subcortical volumes are similarly affected in ASD and ADHD, albeit with small effect sizes. Cortical analyses identified unique differences in each disorder, but also considerable overlap between the two, specifically in cortical thickness. Ongoing work is examining alternative research questions, such as brain laterality, prediction of case-control status, and anatomical heterogeneity. In brief, great strides have been made toward fulfilling the aims of the ENIGMA collaborations, while new ideas and follow-up analyses continue that include more imaging modalities (diffusion MRI and resting-state functional MRI), collaborations with other large databases, and samples with dual diagnoses., Martine Hoogman is supported by a personal Veni grant of the Netherlands Organization for Scientific Research (NWO, grant number 91619115). Odile A. van den Heuvel is supported by a personal VIDI grant of the Netherlands Organization for Scientific Research (NWO/ZonMw, number 91717306). This work has further benefited from grants for the NeuroIMAGE study which was supported by NIH Grant R01MH62873 (to Stephen V. Faraone), NWO Large Investment Grant 1750102007010 (to Jan Buitelaar), ZonMW grant 60‐60600‐97‐193, NWO grants 056‐13‐015 and 433‐09‐242, and matching grants from Radboud University Nijmegen Medical Center, University Medical Center Groningen and Accare, and Vrije Universiteit Amsterdam. This also included support from the European Community's Seventh Framework Programme (FP7/2007‐2013) under grant agreement number 278948 (TACTICS), 602805 (Aggressotype), 603016 (MATRICS), and 602450 (Imagemend), and the Innovation Medicine Initiative grants 115300 (EU‐AIMS) and 777394 (AIMS‐2‐TRIALS). Support was also received from the Dutch National Science Agenda for the NWA NeurolabNL project (grant 400 17 602). The first and senior authors would like to acknowledge the Cognomics Initiative, a joint initiative by researchers of the Donders Centre for Cognitive Neuroimaging, the Human Genetics and Cognitive Neuroscience departments of the Radboud University Medical Center, and the Max Planck Institute for Psycholinguistics in Nijmegen. The Cognomics Initiative has received support from the participating departments and centres and from external grants, that is, the Biobanking and Biomolecular Resources Research Infrastructure (Netherlands) (BBMRI‐NL), the Hersenstichting Nederland, the Netherlands Organization for Scientific Research (NWO), and the European Community's Seventh Framework Programme (FP7/2007–2013) under grant agreements n° 602450 (IMAGEMEND). In addition, the work was supported by a grant for the ENIGMA Consortium (grant number U54 EB020403) from the BD2K Initiative of a cross‐NIH partnership. The POND (Province of Ontario Neurodevelopmental Disorders) data collection was supported by the grant IDS‐I l‐02 (to Evdokia Anagnostou, Jason Lerch) from the Ontario Brain Institute, as well as CIHR support from grants CIHR‐106582, CIHR‐142379 (to Margot Taylor). Initial support for the ENIGMA ADHD and ASD working groups was provided by the U.S. National Institutes of Health Big Data to Knowledge Program (BD2K), under grant U54 EB020403. Joel T. Nigg is supported by an NIH grant R01 MH115357.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Mapping Cortical and Subcortical Asymmetry in Obsessive-Compulsive Disorder: Findings From the ENIGMA Consortium

  • Lázaro García, Luisa
  • Menchón Magriñá, José Manuel
  • Soriano Mas, Carles
  • ENIGMA OCD Working Group
Background: Lateralized dysfunction has been suggested in obsessive-compulsive disorder (OCD). However, it is currently unclear whether OCD is characterized by abnormal patterns of brain structural asymmetry. Here we carried out what is by far the largest study of brain structural asymmetry in OCD. Methods: We studied a collection of 16 pediatric datasets (501 patients with OCD and 439 healthy control subjects), as well as 30 adult datasets (1777 patients and 1654 control subjects) from the OCD Working Group within the ENIGMA (Enhancing Neuro Imaging Genetics through Meta Analysis) Consortium. Asymmetries of the volumes of subcortical structures, and of measures of regional cortical thickness and surface areas, were assessed based on T1-weighted magnetic resonance imaging scans, using harmonized image analysis and quality control protocols. We investigated possible alterations of brain asymmetry in patients with OCD. We also explored potential associations of asymmetry with specific aspects of the disorder and medication status. Results: In the pediatric datasets, the largest case-control differences were observed for volume asymmetry of the thalamus (more leftward; Cohen's d = 0.19) and the pallidum (less leftward; d = -0.21). Additional analyses suggested putative links between these asymmetry patterns and medication status, OCD severity, or anxiety and depression comorbidities. No significant case-control differences were found in the adult datasets. Conclusions: The results suggest subtle changes of the average asymmetry of subcortical structures in pediatric OCD, which are not detectable in adults with the disorder. These findings may reflect altered neurodevelopmental processes in OCD.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Structural neuroimaging biomarkers for obsessive-compulsive disorder in the ENIGMA-OCD consortium: medication matters

  • Alonso, Pino
  • Calvo Escalona, Rosa
  • Lázaro García, Luisa
  • Martínez Zalacaín, Ignacio
  • Menchón Magriñá, José Manuel
  • Morer Liñán, Astrid
  • Pariente, Jose Carlos
  • Soriano Mas, Carles
  • ENIGMA-OCD working group
No diagnostic biomarkers are available for obsessive-compulsive disorder (OCD). Here, we aimed to identify magnetic resonance imaging (MRI) biomarkers for OCD, using 46 data sets with 2304 OCD patients and 2068 healthy controls from the ENIGMA consortium. We performed machine learning analysis of regional measures of cortical thickness, surface area and subcortical volume and tested classification performance using cross-validation. Classification performance for OCD vs. controls using the complete sample with different classifiers and cross-validation strategies was poor. When models were validated on data from other sites, model performance did not exceed chance-level. In contrast, fair classification performance was achieved when patients were grouped according to their medication status. These results indicate that medication use is associated with substantial differences in brain anatomy that are widely distributed, and indicate that clinical heterogeneity contributes to the poor performance of structural MRI as a disease marker.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Identification of ADHD risk genes in extended pedigrees by combining linkage analysis and whole-exome sequencing

  • Corominas, Jordi
  • Klein, Marieke
  • Zayats, Tetyana
  • Rivero, Olga
  • Ziegler, Georg C.
  • Pauper, Marc
  • Neveling, Kornelia
  • Poelmans, Geert
  • Jansch, Charline
  • Svirin, Evgeniy
  • Geissler, Julia
  • Weber, Heike
  • Reif, Andreas
  • Arias Vasquez, Alejandro
  • Galesloot, Tessel E.
  • Kiemeney, Lambertus A. L. M.
  • Buitelaar, Jan K.
  • Ramos Quiroga, Josep Antoni
  • Cormand Rifà, Bru
  • Ribasés Haro, Marta
  • Hveem, Kristian
  • Gabrielsen, Maiken Elvestad
  • Hoffmann, Per
  • Jacob, Christian P.
  • Romanos, Marcel
  • Franke, Barbara
  • Lesch, Klaus-Peter
Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder with a complex genetic background, hampering identification of underlying genetic risk factors. We hypothesized that combining linkage analysis and whole-exome sequencing (WES) in multi-generation pedigrees with multiple affected individuals can point toward novel ADHD genes. Three families with multiple ADHD-affected members (Ntotal = 70) and apparent dominant inheritance pattern were included in this study. Genotyping was performed in 37 family members, and WES was additionally carried out in 10 of those. Linkage analysis was performed using multi-point analysis in Superlink Online SNP 1.1. From prioritized linkage regions with a LOD score ≥ 2, a total of 24 genes harboring rare variants were selected. Those genes were taken forward and were jointly analyzed in gene-set analyses of exome-chip data using the MAGMA software in an independent sample of patients with persistent ADHD and healthy controls (N = 9365). The gene-set including all 24 genes together, and particularly the gene-set from one of the three families (12 genes), were significantly associated with persistent ADHD in this sample. Among the latter, gene-wide analysis for the AAED1 gene reached significance. A rare variant (rs151326868) within AAED1 segregated with ADHD in one of the families. The analytic strategy followed here is an effective approach for identifying novel ADHD risk genes. Additionally, this study suggests that both rare and more frequent variants in multiple genes act together in contributing to ADHD risk, even in individual multi-case families.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Cortical thickness across the lifespan: Data from 17,075 healthy individuals aged 3–90 years

  • Frangou, Sophia
  • Modabbernia, Amirhossein
  • Williams, Steven C. R.
  • Papachristou, Efstathios
  • Doucet, Gaelle E.
  • Agartz, Ingrid
  • Aghajani, Moji
  • Akudjedu, Theophilus N.
  • Albajes Eizagirre, Anton
  • Alnæs, Dag
  • Alpert, Kathryn I.
  • Jönsson, Erik G.
  • Brandeis, Daniel
  • Breier, Alan
  • Glahn, David C.
  • Brodaty, Henry
  • Hatton, Sean N.
  • Mataix-Cols, David
  • Holmes, Avram J.
  • Salvador, Raymond
  • Temmingh, Henk S.
  • Zanetti, Marcus V.
  • Haan, Lieuwe de
  • Brouwer, Rachel M.
  • Andreassen, Ole A.
  • Caseras, Xavier
  • Joska, John A.
  • Castellanos, Francisco X.
  • Cervenka, Simon
  • Chaim-Avancini, Tiffany M.
  • Paloyelis, Yannis
  • Koops, Sanne
  • Naaijen, Jilly
  • Wang, Lei
  • Hosten, Norbert
  • Ching, Christopher R. K.
  • Busatto, Geraldo F.
  • Grabe, Hans Jörgen
  • Conzelmann, Annette
  • Sachdev, Perminder S.
  • Zubicaray, Greig I.
  • Mcdonald, Colm
  • Braber, Anouk
  • Najt, Pablo
  • Dickie, Erin W.
  • Di Giorgio, Annabella
  • Satterthwaite, Theodore D.
  • Doan, Nhat Trung
  • Rinker, Daniel A.
  • Andreasen, Nancy C.
  • Lebedeva, Irina
  • Dørum, Erlend S.
  • Crone, Eveline A.
  • Hoogman, Martine
  • Trollor, Julian N.
  • Fatouros Bergman, Helena
  • Tamnes, Christian K.
  • Grimm, Oliver
  • Ortiz García Foz, Víctor
  • Groenewold, Nynke A.
  • Roffman, Joshua L.
  • Grotegerd, Dominik
  • Gruber, Oliver
  • Tordesillas Gutiérrez, Diana
  • Gruner, Patricia
  • Nakao, Tomohiro
  • Soriano Mas, Carles
  • Pauli, Paul
  • Lee, Won Hee
  • Gur, Rachel E.
  • Franke, Barbara
  • Lázaro García, Luisa
  • Wen, Wei
  • Heinz, Andreas
  • Walton, Esther
  • Howells, Fleur M.
  • Völzke, Henry
  • Sarró, Salvador
  • Hulshoff Pol, Hilleke E.
  • Stein, Dan J., 1962-
  • Huyser, Chaim
  • Jahanshad, Neda
  • Weber, Bernd
  • James, Anthony
  • Rosa, Pedro G. P.
  • Veer, Ilya M.
  • Saykin, Andrew J.
  • Buitelaar, Jan K.
  • McIntosh, Andrew M.
  • Jernigan, Terry L.
  • Hickie, Ian B.
  • Kalnin, Andrew
  • Bargalló Alabart, Núria
  • Kanai, Ryota
  • Andersson, Micael
  • Lesch, Klaus-Peter
  • Thompson, Paul M.
  • Tomyshev, Alexander S.
  • West, John D.
  • Lochner, Christine
  • Veltman, Dick J.
  • Machielsen, Marise W. J.
  • Maingault, Sophie
  • Banaschewski, Tobias
  • Martin, Nicholas G.
  • Strike, Lachlan T.
  • Yoncheva, Yulyia
  • Turner, Jessica A.
  • Crivello, Fabrice
  • Fouche, Jean Paul
  • Pergola, Giulio
  • Martínez Zalacaín, Ignacio
  • Koenders, Laura
  • McMahon, Katie L.
  • Voineskos, Aristotle
  • McPhilemy, Genevieve
  • Menchón Magriñá, José Manuel
  • Medland, Sarah E.
  • Calhoun, Vincent
  • Wassink, Thomas H.
  • Hibar, Derrek P.
  • Baumeister, Sarah
  • Meyer Lindenberg, Andreas
  • Mazoyer, Bernard
  • Serpa, Mauricio H.
  • Nordvik, Jan E.
  • Crespo-Facorro, Benedicto
  • Pomarol-Clotet, Edith
  • Ziegler, Georg C.
  • Portella, Maria J.
  • Potkin, Steven G.
  • Radua, Joaquim
  • Davey, Christopher
  • Asherson, Philip
  • Chubar, Victoria
  • Klyushnik, Tatyana P.
  • Whalley, Heather
  • Reif, Andreas
  • Oosterlaan, Jaap
  • Uhlmann, Anne
  • Sacchet, Matthew D.
  • Fisher, Simon E.
  • Schmaal, Lianne
  • Buckner, Randy L.
  • Schnell, Knut
  • Clark, Vincent P.
  • Schumann, Gunter
  • Sim, Kang
  • Fuentes Claramonte, Paola
  • Smoller, Jordan W.
  • Ehrlich, Stefan
  • Canales Rodríguez, Erick Jorge
  • Bertolino, Alessandro
  • Sommer, Iris
  • Sánchez Juan, Pascual
  • Westlye, Lars T.
  • Hohmann, Sarah
  • Swagerman, Suzanne C.
  • Heslenfeld, Dirk J.
  • Heuvel, Odile A.
  • Dale, Anders M.
  • Meer, Dennis
  • Erk, Susanne
  • Wee, Nic J. A.
  • Haren, Neeltje E. M.
  • Hoekstra, Pieter J.
  • Ent, Dennis
  • Conrod, Patricia
  • Gur, Ruben C.
  • Geus, Eco J. C.
  • Bonvino, Aurora
  • Erp, Theo G. M.
  • Thomopoulos, Sophia I.
  • Baur Streubel, Ramona
  • Kuntsi, Jonna
  • Walter, Henrik
  • Klein, Marieke
  • Wierenga, Lara M.
  • Kahn, Rene
  • Frodl, Thomas
  • Wittfeld, Katharina
  • Harrison, Ben J.
  • Wolf, Daniel H.
  • Worker, Amanda
  • Krämer, Bernd
  • Wright, Margaret J.
  • Espeseth, Thomas
  • Jiang, Jiyang
  • Gotlib, Ian H.
  • Nyberg, Lars
  • Cannon, Dara M.
  • Yang, Kun
  • Wang, Yang
  • Dima, Danai
  • Hartman, Catharine A.
  • Karolinska Schizophrenia Project (KaSP)
  • Boomsma, Dorret I.
  • Borgwardt, Stefan
  • Mcdonald, Brenna C.
  • Ho, Beng Choon
  • Lagopoulos, Jim
  • Bourque, Josiane
Delineating the association of age and cortical thickness in healthy individuals is critical given the association of cortical thickness with cognition and behavior. Previous research has shown that robust estimates of the association between age and brain morphometry require large-scale studies. In response, we used cross-sectional data from 17,075 individuals aged 3-90 years from the Enhancing Neuroimaging Genetics through Meta-Analysis (ENIGMA) Consortium to infer age-related changes in cortical thickness. We used fractional polynomial (FP) regression to quantify the association between age and cortical thickness, and we computed normalized growth centiles using the parametric Lambda, Mu, and Sigma method. Interindividual variability was estimated using meta-analysis and one-way analysis of variance. For most regions, their highest cortical thickness value was observed in childhood. Age and cortical thickness showed a negative association; the slope was steeper up to the third decade of life and more gradual thereafter; notable exceptions to this general pattern were entorhinal, temporopolar, and anterior cingulate cortices. Interindividual variability was largest in temporal and frontal regions across the lifespan. Age and its FP combinations explained up to 59% variance in cortical thickness. These results may form the basis of further investigation on normative deviation in cortical thickness and its significance for behavioral and cognitive outcomes.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

1q21.1 distal copy number variants are associated with cerebral and cognitive alterations in humans

  • Sønderby, Ida E.
  • van der Meer, Dennis
  • Moreau, Clara
  • Kaufmann, Tobias
  • Bragi Walters, G.
  • Ellegaard, Maria
  • Abdellaoui, Abdel
  • Ames, David
  • Amunts, Katrin
  • Andersson, Micael
  • Armstrong, Nicola J.
  • Modenato, Claudia
  • Monereo Sánchez, Jennifer
  • Morris, Derek W.
  • Mühleisen, Thomas W.
  • Pausova, Zdenka
  • Olde Loohuis, Loes M.
  • Peralta, Juan M.
  • Pike, G. Bruce
  • Prieto, Carlos
  • Quinlan, Erin B.
  • Wright, Margaret J.
  • Reinbold, Céline S.
  • Stefansson, Hreinn
  • Reis Marques, Tiago
  • Bernard, Manon
  • Rucker, James J. H.
  • Sachdev, Perminder S.
  • Sando, Sigrid B.
  • Schofield, Peter R.
  • Schork, Andrew J.
  • Schumann, Gunter
  • Agartz, Ingrid
  • Shin, Jean
  • Shumskaya, Elena
  • Stefansson, Kari
  • Silva, Ana I.
  • Sisodiya, Sanjay M.
  • Blackburn, Nicholas B.
  • Steen, Vidar M.
  • Stein, Dan J.
  • Strike, Lachlan T.
  • Suzuki, Ikuo K.
  • Djurovic, Srdjan
  • Tamnes, Christian K.
  • Teumer, Alexander
  • Thalamuthu, Anbupalam
  • Jacquemont, Sébastien
  • Tordesillas-Gutiérrez, Diana
  • Uhlmann, Anne
  • Ulfarsson, Magnus O.
  • Blangero, John
  • van't Ent, Dennis
  • van den Bree, Marianne B. M.
  • Westlye, Lars T.
  • Vanderhaeghen, Pierre
  • Vassos, Evangelos
  • Wen, Wei
  • Wittfeld, Katharina
  • Thompson, Paul M.
  • Boomsma, Dorret I.
  • Andreassen, Ole A.
  • Brodaty, Henry
  • Brouwer, Rachel M.
  • Bülow, Robin
  • Bøen, Rune
  • Groenewold, Nynke A.
  • Cahn, Wiepke
  • Hashimoto, Ryota
  • Calhoun, Vincent
  • Caspers, Svenja
  • Ching, Christopher R. K.
  • Cichon, Sven
  • Ciufolini, Simone
  • Crespo-Facorro, Benedicto
  • Curran, Joanne E.
  • Dale, Anders M.
  • Gústafsson, Ómar
  • Dalvie, Shareefa
  • Dazzan, Paola
  • Hehir-Kwa, Jayne Y.
  • de Geus, de Geus,
  • Zubicaray, Greig I. de
  • de Zwarte, Sonja M. C.
  • Desrivieres, Sylvane
  • Doherty, Joanne L.
  • Donohoe, Gary
  • Draganski, Bogdan
  • Haavik, Jan
  • Ehrlich, Stefan
  • Eising, Else
  • Espeseth, Thomas
  • Hibar, Derrek P.
  • Fejgin, Kim
  • Fisher, Simon E.
  • Fladby, Tormod
  • Frei, Oleksandr
  • Frouin, Vincent
  • Fukunaga, Masaki
  • Haberg, Asta K.
  • Gareau, Thomas
  • Ge,Tian
  • Glahn, David C.
  • Grabe, Hans-Jörgen
  • Hillegers, Manon H. J.
  • Hall, Jeremy
  • Hoffmann, Per
  • Holleran, Laurena
  • Holmes, Avram J.
  • Homuth, Georg
  • Hottenga, Jouke-Jan
  • Murray, Robin M.
  • Hulshoff Pol, Hilleke E.
  • Ophoff, Roel A.
  • Ikeda, Masashi
  • Jahanshad, Neda
  • Jockwitz, Christiane
  • Johansson, Stefan
  • Jönsson, Erik G.
  • Jørgensen, Niklas R.
  • Kikuchi, Masataka
  • Knowles, Emma E. M.
  • Nielsen, Jacob
  • Kumar, Kuldeep
  • Le Hellard, Stephanie
  • Owen, Michael J.
  • Leu, Costin
  • Linden, David E. J.
  • Liu, Jingyu
  • Lundervold, Arvid
  • Lundervold, Astri Johansen
  • Maillard, Anne M.
  • Martin, Nicholas G.
  • Nordvik, Jan E.
  • Martin-Brevet, Sandra
  • Mather, Karen A.
  • Mathias, Samuel R.
  • Paus, Tomas
  • McMahon, Katie L.
  • McRae, Allan F.
  • Medland, Sarah E.
  • Meyer-Lindenberg, Andreas
  • Moberget,
  • Torgeir
  • Nyberg, Lars
ENIGMA-CNV working group., Low-frequency 1q21.1 distal deletion and duplication copy number variant (CNV) carriers are predisposed to multiple neurodevelopmental disorders, including schizophrenia, autism and intellectual disability. Human carriers display a high prevalence of micro- and macrocephaly in deletion and duplication carriers, respectively. The underlying brain structural diversity remains largely unknown. We systematically called CNVs in 38 cohorts from the large-scale ENIGMA-CNV collaboration and the UK Biobank and identified 28 1q21.1 distal deletion and 22 duplication carriers and 37,088 non-carriers (48% male) derived from 15 distinct magnetic resonance imaging scanner sites. With standardized methods, we compared subcortical and cortical brain measures (all) and cognitive performance (UK Biobank only) between carrier groups also testing for mediation of brain structure on cognition. We identified positive dosage effects of copy number on intracranial volume (ICV) and total cortical surface area, with the largest effects in frontal and cingulate cortices, and negative dosage effects on caudate and hippocampal volumes. The carriers displayed distinct cognitive deficit profiles in cognitive tasks from the UK Biobank with intermediate decreases in duplication carriers and somewhat larger in deletion carriers—the latter potentially mediated by ICV or cortical surface area. These results shed light on pathobiological mechanisms of neurodevelopmental disorders, by demonstrating gene dose effect on specific brain structures and effect on cognitive function., 1000BRAINS: The 1000BRAINS study was funded by the Institute of Neuroscience and Medicine, Research Center Juelich, Germany. We thank the Heinz Nixdorf Foundation (Germany) for the generous support of the Heinz Nixdorf Recall Study on which 1000BRAINS is based. We also thank the scientists and the study staff of the Heinz Nixdorf Recall Study and 1000BRAINS. Funding was also granted by the Initiative and Networking Fund of the Helmholtz Association (Caspers) and the European Union’s Horizon 2020 Research and Innovation Programme under Grant Agreement 945539 (Human Brain Project SGA3; Amunts, Caspers, Cichon). Brainscale: The Brainscale study was supported by the Netherlands Organization for Scientific Research MagW 480-04-004 (Dorret I. Boomsma), 51.02.060 (Hilleke E. Hulshoff Pol), 668.772 (Dorret I. Boomsma and Hilleke E. Hulshoff Pol); NWO/SPI 56-464-14192 (Dorret I. Boomsma), the European Research Council (ERC-230374) (Dorret I. Boomsma), High Potential Grant Utrecht University (Hilleke E.Hulshoff Pol) and NWO Brain and Cognition 433-09-220 (Hilleke E.Hulshoff Pol). Betula: The Betula study was funded by the Knut and Alice Wallenberg (KAW) foundation (Nyberg). The Freesurfer segmentations on the Betula sample were performed on resources provided by the Swedish National Infrastructure for Computing (SNIC) at HPC2N (in Umeå, Sweden), partially funded by the Swedish Research Council through grant agreement no. 2018-05973. Brain Imaging Genetics (BIG): This work makes use of the BIG database, first established in Nijmegen, The Netherlands, in 2007. This resource is now part of Cognomics (www.cognomics.nl), a joint initiative by researchers from the Donders Centre for Cognitive Neuroimaging, the Human Genetics and Cognitive Neuroscience departments of the Radboud University Medical Centre and the Max Planck Institute for Psycholinguistics in Nijmegen. The Cognomics Initiative has received support from the participating departments and centres and from external grants, that is, the Biobanking and Biomolecular Resources Research Infrastructure (Netherlands) (BBMRI-NL), the Hersenstichting Nederland and the Netherlands Organization for Scientific Research (NWO). The research leading to these results also receives funding from the NWO Gravitation grant ‘Language in Interaction’, the European Community’s Seventh Framework Programme (FP7/2007-2013) under grant agreement nos. 602450 (IMAGEMEND), 278948 (TACTICS) and 602805 (Aggressotype), as well as from the European Community’s Horizon 2020 programme under grant agreement no. 643051 (MiND) and from ERC-2010-AdG 268800-NEUROSCHEMA. In addition, the work was supported by a grant for the ENIGMA Consortium (grant number U54 EB020403) from the BD2K Initiative of a cross-NIH partnership. deCODE genetics: deCODE genetics acknowledges support from the Innovative Medicines Initiative Joint Undertaking under grant agreement nos. 115008 (NEWMEDS) and 115300 (EUAIMS), of which resources are composed of EFPIA in-kind contribution and financial contribution from the European Union’s Seventh Framework Programme (EU-FP7/2007-2013), EU-FP7-funded grant agreement no. 602450 (IMAGEMEND) and EU-funded FP7-People-2011-IAPP grant agreement no. 286213 (PsychDPC). Dublin: This work was supported by Science Foundation Ireland (SFI grant 12/IP/1359 to Gary Donohoe and grant SFI08/IN.1/B1916-Corvin to Aidan C. Corvin). ECHO-DEFINE: The ECHO study acknowledges funding from a Medical Research Council (MRC) Centre Grant to Michael J. Owen (G0801418), the Wellcome Trust (Institutional Strategic Support Fund (ISSF) to van den Bree and Clinical Research Training Fellowship to Joanne L. Doherty), the Waterloo Foundation (WF 918-1234 to van den Bree), the Baily Thomas Charitable Fund (2315/1 to van den Bree), National Institute of Mental Health (NIMH 5UO1MH101724 to van den Bree and Michael J. Owen), the IMAGINE-2 study (funded by the MRC (MR/T033045/1) to van den Bree, Jeremy Hall and Michael J. Owen), the IMAGINE-ID study (funded by MRC (MR/N022572/1) to Jeremy Hall, van den Bree and Owen). The DEFINE study was supported by a Wellcome Trust Strategic Award (100202/Z/12/Z) to Michael J. Owen. ENIGMA: ENIGMA is supported in part by NIH grants U54 EB20403, R01MH116147 and R56AG058854. NIA T32AG058507; NIH/NIMH 5T32MH073526. EPIGEN-Dublin: The EPIGEN-Dublin cohort was supported by a Science Foundation Ireland Research Frontiers Programme award (08/RFP/GEN1538). EPIGEN-UK (Sisodiya): The work was partly undertaken at UCLH/UCL, which received a proportion of funding from the UK Department of Health’s NIHR Biomedical Research Centres funding scheme. We are grateful to the Wolfson Trust and the Epilepsy Society for supporting the Epilepsy Society MRI scanner. GAP: This work was supported by the National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and the Institute of Psychiatry, Psychology and Neuroscience, King’s College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. GOBS: The GOBS study data collection was supported in part by the National Institutes of Health (NIH) grants: R01 MH078143, R01 MH078111 and R01 MH083824, with work conducted in part in facilities constructed under the support of NIH grant C06 RR020547. GSP: Data were in part provided by the Brain Genomics Superstruct Project (GSP) of Harvard University and Massachusetts General Hospital (MGH) (Principal Investigators: Randy Buckner, Jordan Smoller and Joshua Roffman), with support from the Center for Brain Science Neuroinformatics Research Group, Athinoula A. Martinos Center for Biomedical Imaging, Center for Genomic Medicine and Stanley Center for Psychiatric Research. Twenty individual investigators at Harvard and MGH generously contributed data to the overall project. We would like to thank Randy Buckner for insightful comments and feedback on this work. HUBIN: The HUBIN study was financed by the Swedish Research Council (K2010-62X-15078-07-2, K2012-61X-15078-09-3, 521-2014-3487 K2015-62X-15077-12-3, 2017-00949), the regional agreement on medical training and clinical research between Stockholm County Council and the Karolinska Institutet. HUNT: The HUNT study is a collaboration between HUNT Research Centre (Faculty of Medicine and Movement Sciences, NTNU—Norwegian University of Science and Technology), Nord-Trøndelag County Council, Central Norway Health Authority and the Norwegian Institute of Public Health. HUNT-MRI was funded by the Liaison Committee between the Central Norway Regional Health Authority and the Norwegian University of Science and Technology, and the Norwegian National Advisory Unit for functional MRI. IMAGEN: This work received support from the following sources: the European Union-funded FP6 Integrated Project IMAGEN (reinforcement-related behaviour in normal brain function and psychopathology) (LSHM-CT- 2007-037286), the Horizon 2020 funded ERC Advanced Grant ‘STRATIFY’ (Brain network based stratification of reinforcement-related disorders) (695313), ERANID (Understanding the Interplay between Cultural, Biological and Subjective Factors in Drug Use Pathways) (PR-ST-0416-10004), BRIDGET (JPND: BRain Imaging, cognition Dementia and next generation GEnomics) (MR/N027558/1), Human Brain Project (HBP SGA 2, 785907),the FP7 projects IMAGEMEND(602450; IMAging GEnetics for MENtal Disorders) and MATRICS (603016), the Innovative Medicine Initiative Project EUAIMS (115300-2), the Medical Research Council Grant ‘c-VEDA’ (Consortium on Vulnerability to Externalizing Disorders and Addictions) (MR/N000390/1), the Swedish Research Council FORMAS, the Medical Research Council, the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London, the Bundesministeriumfür Bildung und Forschung (BMBF grants 01GS08152, 01EV0711; eMED SysAlc01ZX1311A; Forschungsnetz AERIAL 01EE1406A, 01EE1406B), the Deutsche Forschungsgemeinschaft (DFG grants, SM 80/7-2, SFB 940/2), the Medical Research Foundation and Medical Research Council (grants MR/R00465X/1 and MR/S020306/1). Further support was provided by grants from: ANR (project AF12-NEUR0008-01—WM2NA, ANR-12-SAMA-0004), the Eranet Neuron (ANR-18-NEUR00002-01), the Fondation de France (00081242), the Fondation pour la Recherche Médicale (DPA20140629802), the Mission Interministérielle de Lutte-contre-les-Drogues-et-les-Conduites-Addictives (MILDECA), the Assistance-Publique-Hôpitaux-de-Paris and INSERM (interface grant), Paris Sud University IDEX 2012, the Fondation de l’Avenir (grant AP-RM-17-013), the Fédération pour la Recherche sur le Cerveau; the National Institutes of Health, Science Foundation Ireland (16/ERCD/3797), USA (Axon, Testosterone and Mental Health during Adolescence; RO1 MH085772-01A1) and by NIH Consortium grant U54 EB020403, supported by a cross-NIH alliance that funds Big Data to Knowledge Centres of Excellence. Lifespan: The study is funded by the Research Council of Norway (230345, 288083 and 223273). NCNG: NCNG sample collection was supported by grants from the Bergen Research Foundation and the University of Bergen, the Dr Einar Martens Fund, the Research Council of Norway, to le Hellard, Steen and Espeseth. The Bergen group was supported by grants from the Western Norway Regional Health Authority (Grant 911593 to Arvid Lundervold, Grant 911397 and 911687 to Astri Johansen Lundervold). NTR: The NTR cohort was supported by the Netherlands Organization for Scientific Research (NWO) and The Netherlands Organisation for Health Research and Development (ZonMW) grants 904-61-090, 985-10-002, 912-10-020, 904-61-193, 480-04-004,463-06-001, 451-04-034, 400-05-717, Addiction-31160008, 016-115-035, 481-08-011, 056-32-010, Middelgroot-911-09-032, OCW_NWO Gravity programme—024.001.003, NWO-Groot 480-15-001/674, Center for Medical Systems Biology (CSMB, NWO Genomics), NBIC/BioAssist/RK(2008.024), Biobanking and Biomolecular Resources Research Infrastructure (BBMRI-NL, 184.021.007 and 184.033.111); Spinozapremie (NWO-56-464-14192), KNAW Academy Professor Award (PAH/6635) and University Research Fellow grant (URF) to Dorret I. Boomsma; Amsterdam Public Health research institute (former EMGO+), Neuroscience Amsterdam research institute (former NCA); the European Science Foundation (ESF, EU/QLRT-2001-01254), the European Community’s Seventh Framework Programme (FP7- HEALTH-F4-2007-2013, grant 01413: ENGAGE and grant 602768: ACTION); the European Research Council (ERC Starting 284167, ERC Consolidator 771057, ERC Advanced 230374), Rutgers University Cell and DNA Repository (NIMH U24 MH068457-06), the National Institutes of Health (NIH, R01D0042157-01A1, R01MH58799-03, MH081802, DA018673, R01 DK092127-04, Grand Opportunity grants 1RC2 MH089951 and 1RC2 MH089995); the Avera Institute for Human Genetics, Sioux Falls, South Dakota (USA). Part of the genotyping and analyses were funded by the Genetic Association Information Network (GAIN) of the Foundation for the National Institutes of Health. Computing was supported by NWO through grant 2018/EW/00408559, BiG Grid, the Dutch e-Science Grid and SURFSARA. OATS: The OATS study has been funded by a National Health & Medical Research Council (NHMRC) and Australian Research Council (ARC) Strategic Award Grant of the Ageing Well, Ageing Productively Programme (ID No. 401162) and NHMRC Project Grants (ID Nos. 1045325 and 1085606). This research was facilitated through Twins Research Australia, a national resource in part supported by an NHMRC Centre for Research Excellence Grant (ID No.: 1079102). We thank the participants for their time and generosity in contributing to this research. We acknowledge the contribution of the OATS research team (https://cheba.unsw.edu.au/project/older-australian-twins-study) to this study. OATS genotyping was partly funded by a Commonwealth Scientific and Industrial Research Organization Flagship Collaboration Fund Grant. Osaka: Osaka study was supported by the Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS: Grant Number JP18dm0207006), Brain/MINDS& beyond studies (Grant Number JP20dm0307002) and Health and Labour Sciences Research Grants for Comprehensive Research on Persons with Disabilities (Grant Number JP20dk0307081) from the Japan Agency for Medical Research and Development (AMED), Grants-in-Aid for Scientific Research (KAKENHI; Grant Numbers JP25293250 and JP16H05375). Some computations were performed at the Research Center for Computational Science, Okazaki, Japan. PAFIP: The PAFIP study was supported by Instituto de Salud Carlos III, FIS 00/3095, 01/3129, PI020499, PI060507, PI10/00183, the SENY Fundació Research Grant CI2005-0308007 and the FundaciónMarqués de Valdecilla API07/011. Biological samples from our cohort were stored at the Valdecilla Biobank and genotyping services were conducted at the Spanish ‘Centro Nacional de Genotipado’ (CEGEN-ISCIII). MCIC/COBRE: The study is funded by the National Institutes of Health studies R01EB006841, P20GM103472 and P30GM122734 and Department of Energy DE-FG02-99ER62764. PING: Data collection and sharing for the Paediatric Imaging, Neurocognition and Genetics (PING) Study (National Institutes of Health Grant RC2DA029475) were funded by the National Institute on Drug Abuse and the Eunice Kennedy Shriver National Institute of Child Health & Human Development. A full list of PING investigators is at http://pingstudy.ucsd.edu/investigators.html. QTIM: The QTIM study was supported by the National Institute of Child Health and Human Development (R01 HD050735) and the National Health and Medical Research Council (NHMRC 486682, 1009064), Australia. Genotyping was supported by NHMRC (389875). Medland is supported in part by an NHMRC fellowship (APP1103623). SHIP: SHIP is part of the Community Medicine Research net of the University of Greifswald, Germany, which is funded by the Federal Ministry of Education and Research (grant nos. 01ZZ9603, 01ZZ0103 and 01ZZ0403), the Ministry of Cultural Affairs and the Social Ministry of the Federal State of Mecklenburg-West Pomerania. Genome-wide single-nucleotide polymorphism typing in SHIP and MRI scans in SHIP and SHIP-TREND have been supported by a joint grant from Siemens Healthineers, Erlangen, Germany and the Federal State of Mecklenburg-West Pomerania. StrokeMRI: StrokeMRI was supported by the Norwegian ExtraFoundation for Health and Rehabilitation(2015/FO5146), the Research Council of Norway (249795, 262372), the South-Eastern Norway Regional Health Authority (2014097, 2015044, 2015073) and the Department of Psychology, University of Oslo. Sydney MAS: The Sydney Memory and Aging Study (Sydney MAS) is funded by National and HealthMedical Research Council (NHMRC) Programme and Project Grants (ID350833, ID568969 and ID109308). We also thank the Sydney MAS participants and the Research Team. SYS: The SYS Study is supported by Canadian Institutes of Health Research. TOP: Centre of Excellence: RCN #23273 and RCN #226971. Part of this work was performed on the TSD (Tjeneste for Sensitive Data) facilities, owned by the University of Oslo, operated and developed by the TSD service group at the University of Oslo, IT-Department (USIT) (tsd-drift@usit.uio.no). The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7-PEOPLE-2013-COFUND) under grant agreement no. 609020—Scientia Fellows; the Research Council of Norway (RCN) #276082—A lifespan perspective on mental illness: toward precision medicine using multimodal brain imaging and genetics. Ida E. Sønderby and Rune Bøen are supported by South-Eastern Norway Regional Health Authority (#2020060). Ida E. Sønderby and Ole A. Andreassen have received funding from the European Union’s Horizon 2020 Research and Innovation Programme under Grant agreement no. 847776 (CoMorMent project) and the KG Jebsen Foundation (SKGJ-MED-021). UCLA_UMCU: The UCLA_UMCU cohort comprises of six studies which were supported by National Alliance for Research in Schizophrenia and Affective Disorders (NARSAD) (20244 to Prof. Hillegers), The Netherlands Organisation for Health Research and Development (ZonMw) (908-02-123 to Prof. Hulshoff Pol), and Netherlands Organisation for Scientific Research (NWO 9120818 and NWO-VIDI 917-46-370 to Prof. Hulshoff Pol). The GROUP study was funded through the Geestkracht programme of the Dutch Health Research Council (ZonMw, grant number 10-000-1001), and matching funds from participating pharmaceutical companies (Lundbeck, AstraZeneca, Eli Lilly and Janssen Cilag) and universities and mental health care organizations (Amsterdam: Academic Psychiatric Centre of the Academic Medical Center and the mental health institutions: GGZ inGeest, Arkin, Dijk en Duin, GGZ Rivierduinen, Erasmus Medical Centre, GGZ Noord-Holland-Noord. Groningen: University Medical Center Groningen and the mental health institutions: Lentis, GGZ Friesland, GGZ Drenthe, Dimence, Mediant, GGNet Warnsveld, Yulius Dordrecht and Parnassia Psycho-medical Center, The Hague. Maastricht: Maastricht University Medical Centre and the mental health institutions: GGzE, GGZ Breburg, GGZ Oost-Brabant, Vincent van Gogh, voor Geestelijke Gezondheid, Mondriaan, Virenzeriagg, Zuyderland GGZ, MET ggz, Universitair Centrum Sint-JozefKortenberg, CAPRI University of Antwerp, PC Ziekeren Sint-Truiden, PZ Sancta Maria Sint-Truiden, GGZ Overpelt, OPZ Rekem. Utrecht: University Medical Center Utrecht and the mental health institutions: Altrecht, GGZ Centraal and Delta.). UK Biobank: This work made use of data sharing from UK Biobank (under project code 27412). Others: Work by Pierre Vanderhaeghen was funded by Grants of the European Research Council (ERC Adv Grant GENDEVOCORTEX), the EOS Programme, the Belgian FWO, the AXA Research Fund and the Belgian Queen Elizabeth Foundation. Ikuo K. Suzuki was supported by a postdoctoral fellowship of the FRS/FNRS., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Cortical thickness across the lifespan: Data from 17,075 healthy individuals aged 3-90 years

  • Frangou, Sophia
  • Modabbernia, Amirhossein
  • Williams, Steven C. R.
  • Papachristou, Efstathios
  • Doucet, Gaelle E.
  • Agartz, Ingrid
  • Aghajani, Moji
  • Akudjedu, Theophilus N.
  • Albajes-Eizagirre, Antón
  • Alnæs, Dag
  • Alpert, Kathryn I.
  • Voineskos, Aristotle
  • Völzke, Henry
  • Walter, Henrik
  • Walton, Esther
  • Wang, Lei
  • Wang, Yang
  • Wassink, Thomas H.
  • Weber, Bernd
  • Bertolino, Alessandro
  • Wen, Wei
  • Kalnin, Andrew
  • West, John D.
  • Westlye, Lars T.
  • Whalley, Heather
  • Wierenga, Lara M.
  • Wittfeld, Katharina
  • Wolf, Daniel H.
  • Worker, Amanda
  • Wright, Margaret J.
  • Yang, Kun
  • Bonvino, Aurora
  • Kanai, Ryota
  • Yoncheva, Yulyia
  • Zanetti, Marcus V.
  • Ziegler, Georg C.
  • Karolinska Schizophrenia Project
  • Thompson, Paul M.
  • Dima, Danai
  • Boomsma, Dorret I.
  • Borgwardt, Stefan
  • Bourque, Josiane
  • Brandeis, Daniel
  • Klein, Marieke
  • Breier, Alan
  • Brodaty, Henry
  • Brouwer, Rachel M.
  • Buitelaar, Jan K.
  • Busatto, Geraldo F.
  • Buckner, Randy L.
  • Calhoun, Vincent
  • Canales-Rodríguez, Erick J.
  • Cannon, Dara M.
  • Caseras, Xavier
  • Klyushnik, Tatyana P.
  • Castellanos, Francisco X.
  • Cervenka, Simon
  • Chaim-Avancini, Tiffany M.
  • Ching, Christopher R. K.
  • Chubar, Victoria
  • Clark, Vincent P.
  • Conrod, Patricia
  • Conzelmann, Annette
  • Crespo-Facorro, Benedicto
  • Crivello, Fabrice
  • Koenders, Laura
  • Crone, Eveline A.
  • Dale, Anders M.
  • Dannlowski, Udo
  • Davey, Christopher
  • Geus, Eco J. C. de
  • Haan, Lieuwe de
  • Zubicaray, Greig I. de
  • den Braber, Anouk
  • Dickie, Erin W.
  • Di Giorgio, Annabella
  • Koops, Sanne
  • Doan, Nhat Trung
  • Dørum, Erlend S.
  • Ehrlich, Stefan
  • Erk, Susanne
  • Espeseth, Thomas
  • Fatouros-Bergman, Helena
  • Fisher, Simon E.
  • Fouche, Jean-Paul
  • Franke, Barbara
  • Frodl, Thomas
  • Krämer, Bernd
  • Fuentes-Claramonte, Paola
  • Glahn, David C.
  • Gotlib, Ian H.
  • Grabe, Hans-Jörgen
  • Grimm, Oliver
  • Groenewold, Nynke A.
  • Grotegerd, Dominik
  • Gruber, Oliver
  • Gruner, Patricia
  • Gur, Rachel E.
  • Kuntsi, Jonna
  • Gur, Ruben C.
  • Hahn, Tim
  • Harrison, Ben J.
  • Hartman, Catharine A.
  • Hatton, Sean N.
  • Heinz, Andreas
  • Heslenfeld, Dirk J.
  • Hibar, Derrek P.
  • Hickie, Ian B.
  • Ho, Beng-Choon
  • Lagopoulos, Jim
  • Hoekstra, Pieter J.
  • Hohmann, Sarah
  • Holmes, Avram J.
  • Hoogman, Martine
  • Hosten, Norbert
  • Howells, Fleur M.
  • Hulshoff Pol, Hilleke E.
  • Huyser, Chaim
  • Jahanshad, Neda
  • James, Anthony
  • Lázaro, Luisa
  • Jernigan, Terry L.
  • Jiang, Jiyang
  • Jönsson, Erik G.
  • Joska, John A.
  • Kahn, René S.
  • Andersson, Micael
  • Lebedeva, Irina
  • Lee, Won Hee
  • Lesch, Klaus-Peter
  • Lochner, Christine
  • Machielsen, Marise W. J.
  • Maingault, Sophie
  • Martin, Nicholas G.
  • Martínez-Zalacaín, Ignacio
  • Mataix-Cols, David
  • Mazoyer, Bernard
  • Andreasen, Nancy C.
  • McDonald, Colm
  • McDonald, Brenna C.
  • McIntosh, Andrew M.
  • McMahon, Katie L.
  • McPhilemy, Genevieve
  • Meinert, Susanne
  • Menchón, José M.
  • Medland, Sarah E.
  • Meyer-Lindenberg, Andreas
  • Naaijen, Jilly
  • Andreassen, Ole A.
  • Najt, Pablo
  • Nakao, Tomohiro
  • Nordvik, Jan E.
  • Nyberg, Lars
  • Oosterlaan, Jaap
  • Ortiz-Garcia de la Foz, Victor
  • Paloyelis, Yannis
  • Pauli, Paul
  • Pergola, Giulio
  • Pomarol-Clotet, Edith
  • Asherson, Philip
  • Portella, Maria J.
  • Potkin, Steven G.
  • Radua, Joaquim
  • Reif, Andreas
  • Rinker, Daniel A.
  • Roffman, Joshua L.
  • Rosa, Pedro G. P.
  • Sacchet, Matthew D.
  • Sachdev, Perminder S.
  • Salvador, Raymond
  • Banaschewski, Tobias
  • Sánchez-Juan, Pascual
  • Sarró, Salvador
  • Satterthwaite, Theodore D.
  • Saykin, Andrew J.
  • Serpa, Mauricio H.
  • Schmaal, Lianne
  • Schnell, Knut
  • Schumann, Gunter
  • Sim, Kang
  • Smoller, Jordan W.
  • Bargalló, Núria
  • Sommer, Iris
  • Soriano-Mas, Carles
  • Stein, Dan J.
  • Strike, Lachlan T.
  • Swagerman, Suzanne C.
  • Tamnes, Christian K.
  • Temmingh, Henk S.
  • Thomopoulos, Sophia I.
  • Tomyshev, Alexander S.
  • Baumeister, Sarah
  • Tordesillas-Gutiérrez, Diana
  • Trollor, Julian N.
  • Turner, Jessica A.
  • Uhlmann, Anne
  • van den Heuvel, Odile A.
  • van den Meer, Dennis
  • van der Wee, Nic J. A.
  • van Haren, Neeltje E. M.
  • van 't Ent, Dennis
  • van Erp, Theo G. M.
  • Baur-Streubel, Ramona
  • Veer, Ilya M.
  • Veltman, Dick J.
Special Issue: The ENIGMA Consortium: the first 10 years., Delineating the association of age and cortical thickness in healthy individuals is critical given the association of cortical thickness with cognition and behavior. Previous research has shown that robust estimates of the association between age and brain morphometry require large-scale studies. In response, we used cross-sectional data from 17,075 individuals aged 3–90 years from the Enhancing Neuroimaging Genetics through Meta-Analysis (ENIGMA) Consortium to infer age-related changes in cortical thickness. We used fractional polynomial (FP) regression to quantify the association between age and cortical thickness, and we computed normalized growth centiles using the parametric Lambda, Mu, and Sigma method. Interindividual variability was estimated using meta-analysis and one-way analysis of variance. For most regions, their highest cortical thickness value was observed in childhood. Age and cortical thickness showed a negative association; the slope was steeper up to the third decade of life and more gradual thereafter; notable exceptions to this general pattern were entorhinal, temporopolar, and anterior cingulate cortices. Interindividual variability was largest in temporal and frontal regions across the lifespan. Age and its FP combinations explained up to 59% variance in cortical thickness. These results may form the basis of further investigation on normative deviation in cortical thickness and its significance for behavioral and cognitive outcomes., European Community's Seventh Framework Programme, Grant/Award Numbers: 278948, 602450, 603016, 602805; US National Institute of Child Health and Human Development, Grant/Award Numbers: RO1HD050735, 1009064, 496682; QIMR Berghofer Medical Research Institute and the Centre for Advanced Imaging, University of Queensland; ICTSI NIH/NCRR, Grant/Award Number: RR025761; European Community's Horizon 2020 Programme, Grant/Award Numbers: 667302, 643051; Vici Innovation Program, Grant/Award Numbers: #91619115, 016-130-669; NWO Brain & Cognition Excellence Program, Grant/Award Number: 433-09-229; Biobanking and Biomolecular Resources Research Infrastructure (Netherlands) (BBMRI-NL); Spinozapremie, Grant/Award Number: NWO-56-464-14192; Biobanking and Biomolecular Resources Research Infrastructure, Grant/Award Numbers: 184.033.111, 184.021.007; Netherlands Organization for Health Research and Development (ZonMW), Grant/Award Numbers: 480-15-001/674, 024.001.003, 911-09-032, 056-32-010, 481-08-011, 016-115-035, 31160008, 400-07-080, 400-05-717, 451-04-034, 463-06-001, 480-04-004, 904-61-193, 912-10-020, 985-10-002, 904-61-090; NIMH, Grant/Award Number: R01 MH090553; Geestkracht programme of the Dutch Health Research Council, Grant/Award Number: 10-000-1001; FP7 Ideas: European Research Council; Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Grant/Award Numbers: NWO/SPI 56-464-14192, NWO-MagW 480-04-004, 433-09-220, NWO 51.02.062, NWO 51.02.061; National Center for Advancing Translational Sciences, National Institutes of Health, Grant/Award Number: UL1 TR000153; National Center for Research Resources; National Center for Research Resources at the National Institutes of Health, Grant/Award Numbers: NIH 1U24 RR025736-01, NIH 1U24 RR021992; NIH Institutes contributing to the Big Data to Knowledge; U.S. National Institutes of Health, Grant/Award Numbers: R01 CA101318, P30 AG10133, R01 AG19771; Medical Research Council, Grant/Award Numbers: U54EB020403, G0500092; National Institute of Mental Health, Grant/Award Numbers: R01MH117014, R01MH042191; Fundación Instituto de Investigación Marqués de Valdecilla, Grant/Award Numbers: API07/011, NCT02534363, NCT0235832; Instituto de Salud Carlos III, Grant/Award Numbers: PI14/00918, PI14/00639, PI060507, PI050427, PI020499; Swedish Research Council, Grant/Award Numbers: 523-2014-3467, 2017-00949, 521-2014-3487; South-Eastern Norway Health Authority; the Research Council of Norway, Grant/Award Number: 223273; South Eastern Norway Regional Health Authority, Grant/Award Numbers: 2017-112, 2019107; Icahn School of Medicine at Mount Sinai; Seventh Framework Programme (FP7/2007-2013), Grant/Award Number: 602450; National Institutes of Health, Grant/Award Numbers: R01 MH116147, R01 MH113619, R01 MH104284; South London and Maudsley NHS Foundation Trust; the National Institute for Health Research (NIHR)
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Genetic variants associated with longitudinal changes in brain structure across the lifespan

  • Brouwer, Rachel M.
  • Tordesillas-Gutiérrez, Diana
  • Crespo-Facorro, Benedicto
  • Hulshoff Pol, Hilleke E.
et al., Human brain structure changes throughout the lifespan. Altered brain growth or rates of decline are implicated in a vast range of psychiatric, developmental and neurodegenerative diseases. In this study, we identified common genetic variants that affect rates of brain growth or atrophy in what is, to our knowledge, the first genome-wide association meta-analysis of changes in brain morphology across the lifespan. Longitudinal magnetic resonance imaging data from 15,640 individuals were used to compute rates of change for 15 brain structures. The most robustly identified genes GPR139, DACH1 and APOE are associated with metabolic processes. We demonstrate global genetic overlap with depression, schizophrenia, cognitive functioning, insomnia, height, body mass index and smoking. Gene set findings implicate both early brain development and neurodegenerative processes in the rates of brain changes. Identifying variants involved in structural brain changes may help to determine biological pathways underlying optimal and dysfunctional brain development and aging., The ENIGMA-Plasticity Working Group is part of the ENIGMA World Aging Center, funded by NIA grants R56 AG058854 and R01 AG058854. The ENIGMA Consortium core funding was supported by NIH Consortium Grant U54 EB020403, supported by a cross-NIH alliance that funds Big Data to Knowledge Centers of Excellence. 1000BRAINS: 1000BRAINS is a population-based cohort based on the Heinz-Nixdorf Recall Study and is supported, in part, by the German National Cohort. We thank the Heinz Nixdorf Foundation (Germany) for their generous support in terms of the Heinz Nixdorf Study. The authors are supported by the Initiative and Networking Fund of the Helmholtz Association (Svenja Caspers) and the European Union’s Horizon 2020 Research and Innovation Programme under grant agreements 785907 (Human Brain Project SGA2; Svenja Caspers, Sven Cichon and Katrin Amunts). This work was further supported by the German Federal Ministry of Education and Research (BMBF) through the Integrated Network IntegraMent (Integrated Understanding of Causes and Mechanisms in Mental Disorders) under the auspices of the e:Med Program (grant 01ZX1314A; Sven Cichon) and by the Swiss National Science Foundation (SNSF, grant 156791; Sven Cichon). The authors acknowledge grants supporting their work from the European Union’s Horizon 2020 Research and Innovation Programme (H2020/2014–2020) under grant agreements 667302 (CoCA), 728018 (Eat2beNICE), 785907 (HBP SGA2) and 772376 (EScORIAL) and the Netherlands ALS Foundation.Additional support is received from the European Community’s Seventh Framework Programme (FP7/2007—2013) under grant agreements n° 602805 (Aggressotype), n° 603016 (MATRICS), n° 602450 (IMAGEMEND) and n° 278948 (TACTICS) and from the European Community’s Horizon 2020 Programme (H2020/2014—2020) under grant agreements n° 643051 (MiND) and n° 667302 (CoCA). FP7 Ideas: the European Research Council (ERC-230374 to D.B.). This work was supported by Spanish Ministry of Science and Innovation, Instituto de Salud Carlos III (SAM16PE07CP1, PI16/02012 and PI19/024), co-financed by ERDF Funds from the European Commission, ‘A way of making Europe’, CIBERSAM; Madrid Regional Government (B2017/BMD-3740 AGES-CM-2), European Union Structural Funds; European Union Seventh Framework Program under grant agreements FP7- HEALTH-2013-2.2.1-2-603196 (Project PSYSCAN) and European Union H2020 Program under the Innovative Medicines Initiative 2 Joint Undertaking (grant agreement 115916, Project PRISM and grant agreement 777394, Project AIMS-2-TRIALS), Fundación Familia Alonso, Fundación Alicia Koplowitz and Fundación Mutua Madrileña. The Horizon 2020 funded ERC Advanced Grant ‘STRATIFY’ (Brain network based stratification of reinforcement-related disorders) (695313). The FP7 project MATRICS (603016). The research leading to these results also received support from the European Community’s Seventh Framework Programme (FP7/2007-2013) under grant agreement 278948 (TACTICS), 602805 (Aggressotype), 603016 (MATRICS) and 602450 (Imagemend) and the Innovation Medicine Initiative grants 115300 (EU-AIMS) and 777394 (AIMS-2-TRIALS).PAFIP: PAFIP was supported by the Instituto de Salud Carlos III (PI14/00639, PI14/00918 and PI17/01056) and Fundación Instituto de Investigación Marqués de Valdecilla (NCT0235832 and NCT025KG Jebsen Stiftelsen and H2020 CoMorMent (847776).34363). European Union Marie Curie Research Training Network (MRTN-CT-2006-035987)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Beyond the global brain differences: Intraindividual variability differences in 1q21.1 distal and 15q11.2 BP1-BP2 deletion carriers

  • Boen, Rune
  • Crespo-Facorro, Benedicto
  • Tordesillas-Gutiérrez, Diana
Rune Boen, et al., [Background]: Carriers of the 1q21.1 distal and 15q11.2 BP1-BP2 copy number variants exhibit regional and global brain differences compared with noncarriers. However, interpreting regional differences is challenging if a global difference drives the regional brain differences. Intraindividual variability measures can be used to test for regional differences beyond global differences in brain structure., [Methods]: Magnetic resonance imaging data were used to obtain regional brain values for 1q21.1 distal deletion (n = 30) and duplication (n = 27) and 15q11.2 BP1-BP2 deletion (n = 170) and duplication (n = 243) carriers and matched noncarriers (n = 2350). Regional intra-deviation scores, i.e., the standardized difference between an individual's regional difference and global difference, were used to test for regional differences that diverge from the global difference., [Results]: For the 1q21.1 distal deletion carriers, cortical surface area for regions in the medial visual cortex, posterior cingulate, and temporal pole differed less and regions in the prefrontal and superior temporal cortex differed more than the global difference in cortical surface area. For the 15q11.2 BP1-BP2 deletion carriers, cortical thickness in regions in the medial visual cortex, auditory cortex, and temporal pole differed less and the prefrontal and somatosensory cortex differed more than the global difference in cortical thickness., [Conclusions]: We find evidence for regional effects beyond differences in global brain measures in 1q21.1 distal and 15q11.2 BP1-BP2 copy number variants. The results provide new insight into brain profiling of the 1q21.1 distal and 15q11.2 BP1-BP2 copy number variants, with the potential to increase understanding of the mechanisms involved in altered neurodevelopment., 1000BRAINS. This work was supported by the Institute of Neuroscience and Medicine (INM-1), Research Centre Julich, European Union’s Horizon 2020 Research and Innovation Programme (Grant No. 945539 [HBP SGA3; SC]), and Joint Lab Supercomputing and Modeling for the Human Brain. We thank the Heinz Nixdorf Foundation for the generous support of the Heinz Nixdorf Study. We also thank the scientists and the study staff of the Heinz Nixdorf Recall Study and 1000BRAINS. We gratefully acknowledge the computing time granted through JARA-HPC on the supercomputer JURECA at Forschungszentrum Julich. TOP: This work was supported by Research Council of Norway (Grant Nos. 23273 (Centre of Excellence, Norwegian Centre for Mental Disorders, NORMENT), Grant Nos. 324252 and 226971). ENIGMA-CNV Working Group. This work was supported by the Research Council of Norway (Grant No. 223273 [to OAA]), South-Eastern Norway Regional Health Authority (Grant No. 2020060 [to IES, RB]), European Union’s Horizon 2020 Research and Innovation Programme (CoMorMent project; Grant No. 847776 [to IES]), Kristian Gerhard Jebsen Stiftelsen (Grant No. SKGJ-MED-021 [to IES]), and National Institute of Mental Health (NIMH) (Grant Nos. U01MH119736, R21MH116473, R01MH085953 [to CEB]), and 1R01MH129858-01A1 [to SJ]. This work was performed on Services for Sensitive Data, University of Oslo, with resources provided by UNINETT Sigma2, the national infrastructure for high performance computing and data storage in Norway. Australian Schizophrenia Research Bank: This work was supported by the Australian National Health and Medical Research Council (NHMRC) (Enabling Grant No. 386500, L3 Investigator Grant No. 1196508 [to CP]), and Program Grant No. APP1150083 [to CP]), Pratt Foundation, Ramsay Health Care, Viertel Charitable Foundation, and Schizophrenia Research Institute. Chief Investigators for the Australian Schizophrenia Research Bank were Vaughan Carr, US, RJS, Assen Jablensky, BJM, Patricia Michie, Stanley Catts, FAH, and CP. ECHO-DEFINE: This work was supported by the Wellcome Trust (Institutional Strategic Support Fund [to MBMvdB] and Clinical Research Training Fellowship Grant No. 102003/Z/13/Z [to JLD]), Waterloo Foundation (Grant No. WF 918-1234 [to MBMvdB]), Baily Thomas Charitable Fund (Grant No. 2315/1 [to MBMvdB]), NIMH (Grant Nos. 5UO1MH101724 and U01MH119738 [to MBMvdB]), IMAGINE-ID and IMAGINE-2 studies (funded by Medical Research Council Grant Nos. MR/N022572/1 and MR/T033045/1 [to MBMvdB]), and Medical Research Council (Centre Grant No. MR/P005748/1 [to MJO]). The DEFINE study was supported by a Wellcome Trust Strategic Award (Grant No. 100202/Z/12/Z [to MJO]). FOR2107 Marburg and Münster: This work is part of the German multicenter consortium “Neurobiology of Affective Disorders: A Translational Perspective on Brain Structure and Function,” supported by the German Research Foundation (Deutsche Forschungsgemeinschaft; Forschungsgruppe/Research Unit FOR2107). Principal investigators with respective areas of responsibility in the FOR2107 consortium: Work Package WP1, FOR2107/MACS cohort and brainimaging: TK (speaker FOR2107; DFG Grant Nos. KI 588/14-1, KI 588/14-2, KI 588/20-1, and KI 588/22-1), UD (co-speaker FOR2107; Grant Nos. DA 1151/5-1, DA 1151/5-2, and DA 1151/6-1), Axel Krug (Grant Nos. KR 3822/5-1 and KR 3822/7-2), IN (Grant Nos. NE 2254/1-2, NE 2254/3-1, and NE 2254/4-1), Carsten Konrad (Grant No. KO 4291/3-1). WP5, genetics: Marcella Rietschel (Grant Nos. RI 908/11-1 and RI 908/11-2), MMN (Grant Nos. NO 246/10-1 and NO 246/10-2), Stephanie Witt (Grant Nos. WI 3439/3-1 and WI 3439/3-2). WP6, multi-method data analytics: AJ (Grant Nos. JA 1890/7-1 and JA 1890/7-2), TH (Grant No. HA 7070/2-2). We are deeply indebted to all study participants and staff. A list of acknowledgments can be found at: www.for2107.de/acknowledgements. UCLA-Utrecht: This work was supported by the NIMH (Grant No. R01 MH090553 [to RAO]). The NIMH had no further role in study design, in the collection, analysis, and interpretation of the data, in the writing of the report, and in the decision to submit the paper for publication. QTIM: This work was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (Grant No. R01 HD050735) and the NHMRC (Grant Nos. 486682 and 1009064). Genotyping was supported by the NHMRC (Grant No. 389875). BETULA: This work was supported by the Knut and Alice Wallenberg Foundation (scholar grant [to LN]). Freesurfer calculations were enabled by resources provided by the Swedish National Infrastructure for Computing at HPC2N, Umeå. SHIP (Study of Health in Pomerania): This work is part of the Community Medicine Research net of the University of Greifswald, Germany, which is supported by the Federal Ministry of Education and Research (Grant Nos. 01ZZ9603, 01ZZ0103, and 01ZZ0403), Ministry of Cultural Affairs, and Social Ministry of the Federal State of Mecklenburg-West Pomerania. Genome-wide data in SHIP have been supported by the Federal Ministry of Education and Research (Grant No. 03ZIK012) and a joint grant from Siemens Healthineers and the Federal State of Mecklenburg-West Pomerania. MRI scans in SHIP and SHIP-TREND have been supported by a joint grant from Siemens Healthineers and the Federal State of Mecklenburg-West Pomerania. PAFIP (Programa de Atención a las Fases Iniciales de Psicosis): This work was supported by the Instituto de Salud Carlos III (Grant Nos. 00/3095, 01/3129, PI020499, PI14/00639, PI17/01056, and PI14/00918), SENY Fundació (Research Grant No. CI2005 0308007), and Fundación Marqués de Valdecilla Instituto de Investigación Sanitaria Valdecilla (Grant Nos. A/02/07, NCT0235832, and NCT02534363). Osaka: This work was supported by the Japan Agency for Medical Research and Development (Grant Nos. JP21wm0425012, JP18dm0307002, JP22wm0525019, and JP22dk0207060) and Japan Society for the Promotion of Science KAKENHI (Grant Nos. JP20H03611, JP22H04926, and 20K15778). Some computations were performed at the Research Center for Computational Science, Okazaki, Japan (Project: NIPS, 18-IMS-C162, 19-IMS-C181, 20-IMS-C162, 21-IMS-C179, 22-IMS-C195). IMAGEN: This work was supported by the European Union–funded FP6 Integrated Project IMAGEN (Reinforcement-Related Behavior in Normal Brain Function and Psychopathology) (Grant No. LSHM-CT-2007-037286), Horizon 2020–funded ERC Advanced Grant STRATIFY (Brain Network Based Stratification of Reinforcement-Related Disorders) (Grant No. 695313), Medical Research Foundation and Medical Research Council (Grants Nos. MR/R00465X/1 and MRF-058-0004-RG-DESRI [Neurobiological Underpinning of Eating Disorders: Integrative Biopsychosocial Longitudinal Analyses in Adolescents] and MR/S020306/1 and MRF-058-0009-RG-DESR-C0759 [Establishing Causal Relationships Between Biopsychosocial Predictors and Correlates of Eating Disorders and Their Mediation by Neural Pathways]), National Institutes of Health (NIH) (Consortium Grant No. U54 EB020403, supported by a cross-NIH alliance that funds Big Data to Knowledge Centres of Excellence, and Grant No. 1R56AG058854-01), National Institute for Health Research Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London, ERANID (Understanding the Interplay Between Cultural, Biological and Subjective Factors in Drug Use Pathways) (Grant No. PR-ST-0416-10004), BRIDGET (JPND: BRain Imaging, cognition Dementia and next generation GEnomics) (Grant No. MR/N027558/1), Human Brain Project (HBP SGA 2) (Grant No. 785907), FP7 project MATRICS (Grant No. 603016), Medical Research Council Grant Consortium on Vulnerability to Externalizing Disorders and Addictions (Grant No. MR/N000390/1), Bundesministerium für Bildung und Forschung (Grant Nos. 01GS08152, 01EV0711, Forschungsnetz AERIAL 01EE1406A, and 01EE1406B), Deutsche Forschungsgemeinschaft (Grant Nos. SM 80/7-2, SFB 940/2, and NE 1383/14-1), Agence Nationale de la Recherche (ANR) (Grant Nos. ANR-12-SAMA-0004 and AAPG2019 [GeBra]), Eranet Neuron (Grant Nos. AF12-NEUR0008-01 [WM2NA], ANR-18-NEUR00002-01 [ADORe], and ANR-12-SAMA-0004), Fondation de France (Grant No. 00081242), Fondation pour la Recherche Médicale (Grant No. DPA20140629802), Mission Interministérielle de Lutte contre les Drogues et les Conduites Addictives, Assistance Publique Hôpitaux de Paris and Institut National de la Santé et de la Recherche Médicale (Interface Grant), Paris Sud University IDEX 2012, Fondation de l’Avenir (Grant No. AP-RM-17-013), and Fédération pour la Recherche sur le Cerveau. MCIC (Mind Clinical Imaging Consortium): This work was supported by the NIH (NIH/National Center for Research Resources Grant No. P41RR14075 [to VC] and Grant No. R01EB005846 [to VC]), Department of Energy (Grant No. DE-FG02-99ER62764), Mind Research Network, Morphometry Biomedical Informatics Research Network (Grant Nos. 1U24 and RR021382A), Function Biomedical Informatics Research Network (Grant No. U24RR021992-01 [to VC], NIH/National Center for Research Resources Grant No. MO1 RR025758-01 [to VC], and NIMH Grant No. 1RC1MH089257 [to VC]), Deutsche Forschungsgemeinschaft (research fellowship [to SE]), and Brain and Behavior Research Foundation (NARSAD Young Investigator Award [to SE]). NTR (Netherlands Twin Register): This work was supported by the Netherlands Organization for Scientific Research (NWO) and Netherlands Organisation for Health Research and Development (Grant Nos. 904-61-090, 985-10-002, 912-10-020, 904-61-193, 480-04-004,463-06-001, 451-04-034, 400-05-717, Addiction-31160008, 016-115-035, 481-08-011, 056-32-010, Middelgroot-911-09-032, OCW_NWO Gravity programme—024.001.003, and NWO-Groot 480-15-001/674), Center for Medical Systems Biology (NWO Genomics), NBIC/BioAssist/RK (Grant No. 2008.024), Biobanking and Biomolecular Resources Research Infrastructure The Netherlands (Grant Nos. 184.021.007 and 184.033.111), Spinozapremie (Grant No. NWO-56-464-14192), Royal Netherlands Academy of Arts and Sciences Academy Professor Award (Grant No. PAH/6635) and University Research Fellow grant (to DIB), Amsterdam Public Health research institute (former EMGO+ Institute for Health and Care Research), Amsterdam Neuroscience (former Neuoscience Campus Amsterdam), European Science Foundation (Grant No. EU/QLRT-2001-01254), European Community’s Seventh Framework Programme (FP7- HEALTH-F4-2007-2013, Grant Nos. 01413: ENGAGE and 602768: ACTION), European Research Council (Grant Nos. ERC Starting 284167, ERC Consolidator 771057, and ERC Advanced 230374), Rutgers University Cell and DNA Repository (NIMH Grant No. U24 MH068457-06), NIH (Grant Nos. R01D0042157-01A1, R01MH58799-03, MH081802, DA018673, and R01 DK092127-04 and Grand Opportunity Grant Nos. 1RC2 MH089951 and 1RC2 MH089995), and Avera Institute for Human Genetics. The genotyping and analyses were partly funded by the Genetic Association Information Network of the Foundation for the National Institutes of Health. Computing was supported by NWO (Grant No. 2018/EW/00408559), BiG Grid, Dutch e-Science Grid, and SURFsara. OATS (Older Australian Twins Study): This work was supported by the NHMRC and Australian Research Council Strategic Award Grant of the Ageing Well, Ageing Productively Program (Grant No. 401162), NHMRC project (seed) grants (Grant Nos. 1024224 and 1025243), NHMRC project grants (Grant Nos. 1045325 and 1085606), and NHMRC program grants (Grant Nos. 568969 and 1093083). The OATS Study was facilitated through access to Twins Research Australia, a national resource supported by a Centre of Research Excellence Grant (Grant No. 1079102) from the NHMRC. We thank the participants for their time and generosity in contributing to this research. We acknowledge the contribution of the OATS research team (https://cheba.unsw.edu.au/project/older-australian-twins-study) to this study. PING (Pediatric Imaging, Neurocognition, and Genetics): This work was supported by the National Institute on Drug Abuse and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (Grant Nos. RC2DA029475 and R01 HD061414). EPIGEN-London/University College London: The work was partly undertaken at University College London Hospitals NHS Foundation Trust/University College London, which received a proportion of funding from the UK Department of Health National Institute for Health Research Biomedical Research Centres funding scheme. We thank the Wolfson Trust and the Epilepsy Society for supporting the Epilepsy Society MRI scanner. OSR (Istituto di Ricovero e Cura a Carattere Scientifico Ospedale San Raffele)-Milan: This work was supported by the European Union H2020 (EU.3.1.1 Grant No. 754740 MOODSTRATIFICATION.EU), Italian Ministry of Health (Grant No. RF-2018-12367249) and Italian Ministry of University and Scientific Research (Grant No. A_201779W93T). Dublin: This work was supported by the European Research Council (Grant No. ERC-2015-STG-677467 [to GD]) and Science Foundation Ireland (Grant No. SFI-16/ERCS/3787 [to GD]). Brain Imaging Genetics (BIG): This work makes use of the BIG database, first established in Nijmegen, the Netherlands, in 2007. This resource is now part of Cognomics (www.cognomics.nl), a joint initiative by researchers from the Donders Centre for Cognitive Neuroimaging, Human Genetics and Cognitive Neuroscience departments of Radboud University Medical Centre, and Max Planck Institute for Psycholinguistics in Nijmegen. The Cognomics Initiative is supported by the participating departments and centers and Biobanking and Biomolecular Resources Research Infrastructure (Netherlands), Hersenstichting Nederland, and NWO. The research leading to these results also receives funding from the NWO (Gravitation Grant No. 024.001.006 Language in Interaction), European Community’s Seventh Framework Programme (FP7/2007-2013) (Grant Nos. 602450 IMAGEMEND, 278948 TACTICS, and 602805 Aggressotype), European Community’s Horizon 2020 programme (Grant Nos. 643051 MiND, and ERC-2010-AdG 268800-NEUROSCHEMA). In addition, the work was supported by the ENIGMA Consortium (Grant No. U54 EB020403) from the BD2K Initiative of a cross-NIH partnership. UK Biobank: This research has been conducted using the UK Biobank Resource under Application Number 27412. OAA has received speaker’s honorarium from Lundbeck, Janssen, and Sunovion and is a consultant to Coretechs.ai. TRM reports personal fees from Pfizer, Lundbeck, Astellas, Janssen, and Angelini outside the submitted work. He is an employee and shareholder of Pasithea Therapeutics. CRKC has received partial research support from Biogen for work unrelated to the topic of this article (principal investigator, PMT). PMT has received partial research support from Biogen for work unrelated to the topic of this article. MBMvdB and MJO report grants from Takeda Pharmaceuticals outside the submitted work. MJO reports a grant from Akrivia Health outside the submitted work. HJG has received travel grants and speaker’s honoraria from Fresenius Medical Care, Neuraxpharm, Servier, and Janssen as well as research funding from Fresenius Medical Care. GS has received honoraria for participating at advisory board meetings from Roche and Biogen regarding new Alzheimer’s disease drugs. KKS has received consultant and speaker’s honoraria from Roche and OrionPharma, reimbursement of travel and accommodation costs at a meeting from Kolpharma, and sponsorships for arranging conferences from Desitin and Eisai AB. IG has received speaker’s honorarium from Lundbeck. MMN has received fees for membership in an advisory board from HMG Systems Engineering GmbH, for membership in the Medical-Scientific Editorial Office of the Deutsches Ärzteblatt, and for serving as a consultant for Everis Belgium in a project of the European Commission (REFORM/SC2020/029). MMN also receives salary payments from Life & Brain GmbH and holds shares in Life & Brain GmbH. All these concerned activities outside the submitted work. CP received honoraria for talks from Lundbeck, Australia Pty Ltd. outside the submitted work. DJS has received consultancy honoraria from Discovery Vitality, Johnson & Johnson, Kanna, L’Oreal, Lundbeck, Orion, Sanofi, Servier, Takeda and Vistagen. JH has received speaker’s honorarium from Medice and Takeda outside the submitted work. KP reports work with Novo Nordisk and Roche clinical trials outside the submitted work. All other authors report no biomedical financial interests or potential conflicts of interest., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Lack of replication of previous autism spectrum disorder GWAS hits in European populations

  • Torrico, Bàrbara
  • Chiocchetti, Andreas G.
  • Bacchelli, Elena
  • Trabetti, Elisabetta
  • Hervás, Amaia
  • Franke, Barbara
  • Buitelaar, Jan K.
  • Rommelse, Nanda
  • Yousaf, Afsheen
  • Duketis, Eftichia
  • Freitag, Christine M.
  • Caballero-Andaluz, Rafaela
  • Martinez-Mir, Amalia
  • Scholl, Francisco G.
  • Ribasés, Marta
  • Battaglia, Agatino
  • Malerba, Giovanni
  • Delorme, Richard
  • Benabou, Marion
  • Maestrini, Elena
  • Bourgeron, Thomas
  • Cormand, Bru
  • Toma, Claudio
Common variants contribute significantly to the genetics of autism spectrum disorder (ASD), although the identification of individual risk polymorphisms remains still elusive due to their small effect sizes and limited sample sizes available for association studies. During the last decade several genome-wide association studies (GWAS) have enabled the detection of a few plausible risk variants. The three main studies are family-based and pointed at SEMA5A (rs10513025), MACROD2 (rs4141463) and MSNP1 (rs4307059). In our study we attempted to replicate these GWAS hits using a case-control association study in five European populations of ASD patients and gender-matched controls, all Caucasians. Results showed no association of individual variants with ASD in any of the population groups considered or in the combined European sample. We performed a meta-analysis study across five European populations for rs10513025 (1,904 ASD cases and 2,674 controls), seven European populations for rs4141463 (2,855 ASD cases and 36,177 controls) and five European populations for rs4307059 (2,347 ASD cases and 2,764 controls). The results showed an odds ratio (OR) of 1.05 (95% CI = 0.84-1.32) for rs10513025, 1.0002 (95% CI = 0.93-1.08) for rs4141463 and 1.01 (95% CI = 0.92-1.1) for rs4307059, with no significant P-values (rs10513025, P = 0.73; rs4141463, P = 0.95; rs4307059, P = 0.9). No association was found when we considered either only high functioning autism (HFA), genders separately or only multiplex families. Ongoing GWAS projects with larger ASD cohorts will contribute to clarify the role of common variation in the disorder and will likely identify risk variants of modest effect not detected previously. Autism Res 2017, 10: 202-211. © 2016 International Society for Autism Research, Wiley Periodicals, Inc., The work was funded by Fundació La Marató de TV3 (092010, 092330/31), European commission (PIEF-GA-2009-254930), AGAUR (2014SGR932, 2014SGR1357), Spanish “Ministerio de Economía y Competitividad” (SAF2012-33484, SAF2015-68341-R, SAF2010-21165), Fundación Alicia Koplowitz, University of Bologna (RFO), Instituto de Salud Carlos III (PI14/01700), NHMRC (1066177), Saarland University (T6 03 10 00-45 to C.M.F.), the European Commission and the German Bundesministerium für Bildung und Forschung BMBF (ERA-NET NEURON project: EUHFAUTISM) (EUHFAUTISM-01EW1105 to C.M.F.), the European Commision FP6 framework (AUTISM MOLGEN, 512158, to C.M.F.), ERA-NET NEURON (EUHFAUTISM, PIM2010ERN-00700 to F.G.S.). Collecting the Dutch samples was supported by grants from Karakter Child and Adolescent Psychiatry (to Jan Buitelaar) and a grant by the Netherlands Organisation for Scientific Research (NWO grant # 91610024 assigned to N. Rommelse), the European Union IMI programme EU-AIMS (115300), the FP7 programme TACTICS (278948) and the Horizon2020 programmes BRAINVIEW (642996), MiND (643051) and CoCA (667302). Marta Ribasés is a recipient of a Miguel de Servet contract from the Instituto de Salud Carlos III, Spain (CPII15/00023). The authors declare no conflicts of interest., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Genomic analysis of intracranial and subcortical brain volumes yields polygenic scores accounting for variation across ancestries

  • García-Marín, Luis M.
  • Campos, Adrian I.
  • Diaz-Torres, Santiago
  • Crespo-Facorro, Benedicto
  • Romero García, Rafael
  • Tordesillas-Gutiérrez, Diana
  • Vázquez-Bourgon, Javier
García-Marín, Luis M.; Campos, Adrian I.; Diaz-Torres, Santiago; et al., Subcortical brain structures are involved in developmental, psychiatric and neurological disorders. Here we performed genome-wide association studies meta-analyses of intracranial and nine subcortical brain volumes (brainstem, caudate nucleus, putamen, hippocampus, globus pallidus, thalamus, nucleus accumbens, amygdala and the ventral diencephalon) in 74,898 participants of European ancestry. We identified 254 independent loci associated with these brain volumes, explaining up to 35% of phenotypic variance. We observed gene expression in specific neural cell types across differentiation time points, including genes involved in intracellular signaling and brain aging-related processes. Polygenic scores for brain volumes showed predictive ability when applied to individuals of diverse ancestries. We observed causal genetic effects of brain volumes with Parkinson's disease and attention-deficit/hyperactivity disorder. Findings implicate specific gene expression patterns in brain development and genetic variants in comorbid neuropsychiatric disorders, which could point to a brain substrate and region of action for risk genes implicated in brain diseases., This project has received funding from the European Union's Horizon 2020 Research and Innovation Programme under the Specific Grant Agreement 945539 (Human Brain Project SGA3). This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 643417, No 640643, and No 667375 and 754517. IMAGEN was funded by the European Union-funded FP6 Integrated Project IMAGEN (LSHM-CT- 2007-037286). The MCIC study was supported by the National Institutes of Health (NIH/NCRR P41RR14075 and R01EB005846), the Department of Energy (DE-FG02-99ER62764). NeuroIMAGE also received funding from the European Community’s Seventh Framework Programme (FP7/2007– 2013) under grant agreements n° 602805 (Aggressotype), n° 278948 (TACTICS), and n° 602450 (IMAGEMEND), and from the European Community’s Horizon 2020 Programme (H2020/2014– 2020) under grantagreements n°643051(MiND), n° 667302 (CoCA), and n° 728018 (Eat2beNICE). Additional support is received from the European Community's Seventh Framework Programme (FP7/2007– 2013) under grant agreements nº 602805 (Aggressotype), nº 603016 (MATRICS), nº 602450 (IMAGEMEND), and nº 278948 (TACTICS), and from the European Community's Horizon 2020 Programme (H2020/2014– 2020) under grant agreements nº 643051 (MiND) and nº 667302(CoCA). Erasmus Rucphen family study (ERF): The ERF study as a part of EUROSPAN (European Special Populations Research Network) was supported by European Commission FP6 STRP grant number 018947 (LSHG-CT-2006-01947) and also received funding from the European Community's Seventh Framework Programme (FP7/2007-2013)/grant agreement HEALTH-F4-2007-201413 by the European Commission under the programme "Quality of Life and Management of the Living Resources" of 5th Framework Programme (no.QLG2-CT-2002-01254). the European Science Foundation (ESF, EU/QLRT-2001-01254), the European Community’s Seventh Framework Programme (FP7- HEALTH-F4-2007-2013, grant 01413: ENGAGE and grant 602768: ACTION); the European Research Council (ERC Starting 284167, ERC Consolidator 771057, ERC Advanced 230374). The Horizon 2020 supported programme CANDY Grant No. 847818). European Community’s Horizon 2020 Programme (H2020/2014– 2020) under grant agreement n° 847879 (PRIME). European Research Council under the European Union's Horizon 2020 research and Innovation program (ERC StG, Grant 802998). This work was supported by Fundación Marqués de Valdecilla, Instituto de investigación sanitaria Valdecilla., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Regional, functional and transcriptomic decoding of multidimensional brain structure alterations in obsessive-compulsive disorder

  • Cardoso Saraiva, Leonardo
  • Sato, Joao R.
  • Sebenius, Isaac
  • Dzinalija, Nadza
  • Río-Torné, Carla del
  • Godinho, Fábio
  • Lopes, Antonio C.
  • Fernandez, Thomas V.
  • Lima, Monicke O.
  • Ramos, Vanessa R.
  • Iglesio, Ricardo
  • Abe, Yoshinari
  • Alonos, Pino
  • Ameis, Stephanie H.
  • Anticevic, Alan
  • Araújo, Ana
  • Arnold, Paul D.
  • Balachander, Srinivas
  • Banaj, Nerisa
  • Batistuzzo, Marcelo C.
  • Benedetti, Francesco
  • Bollettini, Irene
  • Bravi, Beatrice
  • Brennan, Brian
  • Buitelaar, Jan
  • Castelo-Branco, Miguel
  • Choi, Sunah
  • Costa, Ana D.
  • Dellaspezia, Sara
  • Denys, Damiaan
  • Duarte, Isabel C.
  • Echevarria, Marco A. N.
  • Eng, Goi Khia
  • Fernandes, Afonso
  • Feusner, Jamie D.
  • Figee, Martijn
  • Fitzsimmons, Sophie M. D. D.
  • Fontenelle, Leonardo F.
  • Grazioplene, Rachael
  • Ha, Minji
  • Hinojosa, Alejandro
  • Hoexter, Marcelo Q.
  • Huijser, Chaim
  • Hu, Hao
  • James, Anthony
  • Kim, Minah
  • Kwon, Jun Soo
  • Lázaro, Luisa
  • Lochner, Christine
  • Machado-Sousa, Mafalda
  • Van Marle, Hein
  • Martínez-Zalacaín, Ignacio
  • Mataix-Cols, David
  • Menchón, José M.
  • Minuzzi, Luciano
  • Morgado, Pedro
  • Muñoz-Moreno, Emma
  • Nakao, Tomohiro
  • Narayanaswamy, Janardhanan C.
  • Nurmi, Erika L.
  • O'Neill, Joseph
  • Park, Inkyung
  • Philips, Mary L.
  • Piacentini, John C.
  • Pico-Pérez, María
  • Piras, Fabrizio
  • Piras, Federica
  • Postma, Tjardo S.
  • Li, Chiang-shan R.
  • Reddy, Janardhan Y. C.
  • Van Rooj, Daan
  • Sakai, Yuki
  • Andrade, Juliana B.
  • Scheffler, Freda
  • Shivakumar, Venkataram
  • Soreni, Noam
  • Stern, Emily R.
  • Van der Straten, Anouk
  • Thomopoulos, Sophia I.
  • Tomiyama, Hirofumi
  • Tovar-Moll, Fernanda
  • Vecchio, Daniela
  • Veltman, Dick J.
  • Venkatasubramanian, Ganesan
  • Vriend, Chris
  • Wang, Zhen
  • Van der Werf, Ysbrand
  • Van Wingen, Guido
  • Zhao, Qing
  • ENIGMA-OCD Working Group
  • Charney, Alexander W.
  • Cho, Youngsun T.
  • Shavitt, Roseli G.
  • Pushkarskaya, Helen
  • Soriano-Mas, Carles
  • Romero-García, Rafael
  • Thompson, Paul M.
  • Stein, Dan J.
  • Van den Heuvel, Odile A.
  • Winkler, Anderson M.
  • Miguel Filho, Euripides C.
  • Pittenger, Christopher
  • Cappi, Carolina
Studies of brain morphology in mental illness often focus on a few neuroimaging phenotypes. Here we present a comprehensive morphological characterization in obsessive-compulsive disorder (OCD) in a large sample (2255 OCD, 2264 controls) using nine cortical and four subcortical phenotypes, including several not previously examined in OCD, among them a subcortical structural similarity network phenotype developed here. Spatially distinct regional alterations emerged across structural phenotypes: cortical curvature alterations in default mode and frontoparietal networks, increased structural similarity network node degree in sensorimotor regions, widespread volume reductions associated with medication use, and localized subcortical shape alterations. In brain-behavior predictive models, curvature phenotypes showed the strongest associations with clinical features. Cortical alterations, especially in structural similarity networks, were associated with specific gene expression patterns, implicating dysregulation of excitatory neurons. RNA-sequencing data from tissue collected during functional neurosurgery revealed that genes downregulated in the dorsolateral prefrontal cortex in OCD contributed to the gene expression patterns linked to cortical alterations. Previously reported differentially expressed genes from postmortem brain studies of OCD also contributed. These findings support the importance of a comprehensive approach to characterizing brain morphology and suggest that cortical curvature and structural similarity alterations reflect key pathophysiological processes in OCD., L.C.S. was supported by the International OCD Foundation 2025 Jenike Young Investigator Award, NIH grant R01MH130609 (to C.P.), and Sao Paulo Research Foundation scholarships 2020/12484-6 and 2022/10207-0. J.R.S. was supported by Sao Paulo Research Foundation grants 2023/18337-3 and 2023/02538-0. N.D. was supported by the International OCD Foundation Innovator Award of 2021. Y.A. was supported by the Japan Society for the Promotion of Science (JSPS; KAKENHI) grant 23K14825. P.A. was supported by PI22/00752 from Instituto de Salud Carlos III and MAR22005 from Fundació La Marató. S.H.A. was supported by the Canadian Institutes of Health Research, the Canada Research Chairs Program, the University of Toronto, and the CAMH Foundation. A.A. was supported by the Portuguese Foundation for Science and Technology (grant 2020.08114.BD). P.D.A. was supported by the Ontario Brain Institute, the Hotchkiss Brain Institute, the Alberta Children’s Hospital Foundation, and the Alberta Innovates Translational Health Chair in Child and Youth Mental Health, and holds a patent for SLCIAI Marker for Anxiety Disorder granted May 6, 2008. S.B. was supported by a Río Hortega grant (CM21/00278) from the Carlos III Health Institute (co-funded by the European Social Fund, Investing in Your Future). J.B. was supported by the European Union 7th Framework Program TACTICS consortium (grant 278948). J.C. was supported by the Portuguese Foundation for Science and Technology (grants DL 57/2016/CP1370/CT0066 and CEECINST/00117/2021/CP2784/CT0001). M.C.B. was supported by the Portuguese Foundation for Science and Technology (grant UIDP/4950/2020). A.D.C. was supported by a PhD scholarship from the Portuguese Foundation for Science and Technology (FCT; reference 2022.09472.BD). I.C.D. was supported by the Portuguese Foundation for Science and Technology (grants UIDP/4950/2020 and 2022.04701.PTDC). G.K.E. was supported by NIH grants R21/R33MH107589 and R01MH111794 (awarded to E.R.S.). A.F. was supported by a PhD scholarship from the Portuguese Foundation for Science and Technology (FCT; reference 2022.12528.BD). J.D.F. was supported by NIMH grant R01MH085900. L.F.F. was supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico (#302526/2018-8), Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (#CNE E-26/200.950/2021), and the D’Or Institute of Research and Education (IDOR). J.I. was supported by NIMH grant R01MH131022. M.K. was supported by the Brain Science Convergence Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Science & ICT (grant RS-2023-00266120). L.L. was supported by the Marató Foundation grants 01/2010 and 091710. C.L. was supported by the National Research Foundation of South Africa. M.M.S. was supported by a PhD scholarship from the Portuguese Foundation for Science and Technology (FCT; reference 2020.07946.BD). D.M.C. was supported by the International OCD Foundation Breakthrough Grant, the Swedish Brain Foundation (Hjärnfonden; FO2017-0154 and FO2020-0139), and the Region Stockholm ALF Medicine funding program (20200137). P.M. was supported by Portuguese Foundation for Science and Technology projects UIDB/50026/2020, UIDP/50026/2020, and LA/P/0050/2020, and by project NORTE-01-0145-FEDER-000039 through the European Regional Development Fund. T.N. was supported by JSPS KAKENHI grant JP21K07547. J.C.N. was supported by the Department of Science and Technology (DST INSPIRE faculty grant IFA12-LSBM-26) and the Department of Biotechnology (BT/06/IYBA/2012). J.O. was supported by NIMH grants R01MH085900 and R01MH081864. J.C.P. was supported by NIMH grant R01MH081864. M.P.P. was supported by grant RYC2021-031228-I funded by MCIN/AEI/10.13039/501100011033 and by the European Union NextGenerationEU/PRTR. F.P. was supported by the Italian Ministry of Health (Ricerca Corrente 2024). Y.C.J.R. was supported by the Department of Science and Technology (SR/S0/HS/0016/2011) and the Department of Biotechnology (BT/PR13334/Med/30/259/2009). Y.S. was supported by AMED grants JP23wm0625001 and JP24wm0625204. J.B.S.A. was supported by a postdoctoral scholarship from Fundação Maria-Emília (Brazil). E.R.S. was supported by NIH grants R21/R33MH107589 and R01MH111794. S.I.T. was supported by NIH grant R01MH138569 (MEGA-OCD). H.T. was supported by JSPS KAKENHI grant JP22K15766. F.T.M. was supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, the D’Or Institute for Research and Education, and Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro. G.V. was supported by the Wellcome-DBT India Alliance grant 500236/Z/11/Z. C.V. was supported by the International OCD Foundation Innovator Award of 2021. Z.W. was supported by the Key Program of the National Natural Science Foundation of China (82230045). A.W. was supported by JSPS KAKENHI grant 21K15749. G.V.W. was supported by ZonMw grants 165.610.002 and 016.156.318. Y.T.C. was supported by Neumora Therapeutics (formerly BlackThorn Therapeutics). C.S.M. was supported by Instituto de Salud Carlos III (PI16/00889, PI19/01171), Departament de Salut (PERIS SLT006/17/249), Fundació Marató de TV3 (202201-31), Agència de Gestió d’Ajuts Universitaris i de Recerca (2021SGR01017), and Ministerio de Ciencia e Innovación (PID2022−139081OB-C21). R.R.G. was supported by the EMERGIA Junta de Andalucía program (EMERGIA20_00139), Plan de Consolidación (CNS2023-143647), and Plan de Generación de Conocimiento (PID2021-122853OA-I00) of the Agencia Estatal de Investigación. P.M.T. was supported by NIH grant R01MH138569 (MEGA-OCD). D.J.S. was supported by the South African Medical Research Council (SAMRC). O.A.H. was supported by the International OCD Foundation Innovator Award of 2021 and by NIMH grant R01MH138569-01 (MEGA-OCD). C.P. was supported by NIH grant R01MH116038. C.C. was supported by NIH grant 1K99MH128540-01., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Analysis of structural brain asymmetries in attention-deficit/hyperactivity disorder in 39 datasets

  • Postema, Merel C.
  • Vilarroya, Óscar
  • Francks, Clyde
Objective: Some studies have suggested alterations of structural brain asymmetry in attention-deficit/hyperactivity disorder (ADHD), but findings have been contradictory and based on small samples. Here, we performed the largest ever analysis of brain left-right asymmetry in ADHD, using 39 datasets of the ENIGMA consortium. Methods: We analyzed asymmetry of subcortical and cerebral cortical structures in up to 1,933 people with ADHD and 1,829 unaffected controls. Asymmetry Indexes (AIs) were calculated per participant for each bilaterally paired measure, and linear mixed effects modeling was applied separately in children, adolescents, adults, and the total sample, to test exhaustively for potential associations of ADHD with structural brain asymmetries. Results: There was no evidence for altered caudate nucleus asymmetry in ADHD, in contrast to prior literature. In children, there was less rightward asymmetry of the total hemispheric surface area compared to controls (t = 2.1, p = .04). Lower rightward asymmetry of medial orbitofrontal cortex surface area in ADHD (t = 2.7, p = .01) was similar to a recent finding for autism spectrum disorder. There were also some differences in cortical thickness asymmetry across age groups. In adults with ADHD, globus pallidus asymmetry was altered compared to those without ADHD. However, all effects were small (Cohen's d from -0.18 to 0.18) and would not survive study-wide correction for multiple testing. Conclusion: Prior studies of altered structural brain asymmetry in ADHD were likely underpowered to detect the small effects reported here. Altered structural asymmetry is unlikely to provide a useful biomarker for ADHD, but may provide neurobiological insights into the trait.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Structural neuroimaging biomarkers for obsessive-compulsive disorder in the ENIGMA-OCD consortium: medication matters

  • Alonso, Pino
  • Calvo Escalona, Rosa
  • Lázaro García, Luisa
  • Martínez Zalacaín, Ignacio
  • Menchón Magriñá, José Manuel
  • Morer Liñán, Astrid
  • Pariente, Jose Carlos
  • Soriano Mas, Carles
  • ENIGMA-OCD working group
No diagnostic biomarkers are available for obsessive-compulsive disorder (OCD). Here, we aimed to identify magnetic resonance imaging (MRI) biomarkers for OCD, using 46 data sets with 2304 OCD patients and 2068 healthy controls from the ENIGMA consortium. We performed machine learning analysis of regional measures of cortical thickness, surface area and subcortical volume and tested classification performance using cross-validation. Classification performance for OCD vs. controls using the complete sample with different classifiers and cross-validation strategies was poor. When models were validated on data from other sites, model performance did not exceed chance-level. In contrast, fair classification performance was achieved when patients were grouped according to their medication status. These results indicate that medication use is associated with substantial differences in brain anatomy that are widely distributed, and indicate that clinical heterogeneity contributes to the poor performance of structural MRI as a disease marker.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Identification of ADHD risk genes in extended pedigrees by combining linkage analysis and whole-exome sequencing

  • Corominas, Jordi
  • Klein, Marieke
  • Zayats, Tetyana
  • Rivero, Olga
  • Ziegler, Georg C.
  • Pauper, Marc
  • Neveling, Kornelia
  • Poelmans, Geert
  • Jansch, Charline
  • Svirin, Evgeniy
  • Geissler, Julia
  • Weber, Heike
  • Reif, Andreas
  • Arias Vasquez, Alejandro
  • Galesloot, Tessel E.
  • Kiemeney, Lambertus A. L. M.
  • Buitelaar, Jan K.
  • Ramos Quiroga, Josep Antoni
  • Cormand Rifà, Bru
  • Ribasés Haro, Marta
  • Hveem, Kristian
  • Gabrielsen, Maiken Elvestad
  • Hoffmann, Per
  • Jacob, Christian P.
  • Romanos, Marcel
  • Franke, Barbara
  • Lesch, Klaus-Peter
Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder with a complex genetic background, hampering identification of underlying genetic risk factors. We hypothesized that combining linkage analysis and whole-exome sequencing (WES) in multi-generation pedigrees with multiple affected individuals can point toward novel ADHD genes. Three families with multiple ADHD-affected members (Ntotal = 70) and apparent dominant inheritance pattern were included in this study. Genotyping was performed in 37 family members, and WES was additionally carried out in 10 of those. Linkage analysis was performed using multi-point analysis in Superlink Online SNP 1.1. From prioritized linkage regions with a LOD score ≥ 2, a total of 24 genes harboring rare variants were selected. Those genes were taken forward and were jointly analyzed in gene-set analyses of exome-chip data using the MAGMA software in an independent sample of patients with persistent ADHD and healthy controls (N = 9365). The gene-set including all 24 genes together, and particularly the gene-set from one of the three families (12 genes), were significantly associated with persistent ADHD in this sample. Among the latter, gene-wide analysis for the AAED1 gene reached significance. A rare variant (rs151326868) within AAED1 segregated with ADHD in one of the families. The analytic strategy followed here is an effective approach for identifying novel ADHD risk genes. Additionally, this study suggests that both rare and more frequent variants in multiple genes act together in contributing to ADHD risk, even in individual multi-case families.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Mapping Cortical and Subcortical Asymmetry in Obsessive-Compulsive Disorder: Findings From the ENIGMA Consortium

  • Lázaro García, Luisa
  • Menchón Magriñá, José Manuel
  • Soriano Mas, Carles
  • ENIGMA OCD Working Group
Background: Lateralized dysfunction has been suggested in obsessive-compulsive disorder (OCD). However, it is currently unclear whether OCD is characterized by abnormal patterns of brain structural asymmetry. Here we carried out what is by far the largest study of brain structural asymmetry in OCD. Methods: We studied a collection of 16 pediatric datasets (501 patients with OCD and 439 healthy control subjects), as well as 30 adult datasets (1777 patients and 1654 control subjects) from the OCD Working Group within the ENIGMA (Enhancing Neuro Imaging Genetics through Meta Analysis) Consortium. Asymmetries of the volumes of subcortical structures, and of measures of regional cortical thickness and surface areas, were assessed based on T1-weighted magnetic resonance imaging scans, using harmonized image analysis and quality control protocols. We investigated possible alterations of brain asymmetry in patients with OCD. We also explored potential associations of asymmetry with specific aspects of the disorder and medication status. Results: In the pediatric datasets, the largest case-control differences were observed for volume asymmetry of the thalamus (more leftward; Cohen's d = 0.19) and the pallidum (less leftward; d = -0.21). Additional analyses suggested putative links between these asymmetry patterns and medication status, OCD severity, or anxiety and depression comorbidities. No significant case-control differences were found in the adult datasets. Conclusions: The results suggest subtle changes of the average asymmetry of subcortical structures in pediatric OCD, which are not detectable in adults with the disorder. These findings may reflect altered neurodevelopmental processes in OCD.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Consortium neuroscience of attention deficit/hyperactivity disorder and autism spectrum disorder: the ENIGMA adventure

  • Hoogman, Martine
  • Vilarroya, Óscar
  • Franke, Barbara
Neuroimaging has been extensively used to study brain structure and function in individuals with attention deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) over the past decades. Two of the main shortcomings of the neuroimaging literature of these disorders are the small sample sizes employed and the heterogeneity of methods used. In 2013 and 2014, the ENIGMA-ADHD and ENIGMA-ASD working groups were respectively, founded with a common goal to address these limitations. Here, we provide a narrative review of the thus far completed and still ongoing projects of these working groups. Due to an implicitly hierarchical psychiatric diagnostic classification system, the fields of ADHD and ASD have developed largely in isolation, despite the considerable overlap in the occurrence of the disorders. The collaboration between the ENIGMA-ADHD and -ASD working groups seeks to bring the neuroimaging efforts of the two disorders closer together. The outcomes of case-control studies of subcortical and cortical structures showed that subcortical volumes are similarly affected in ASD and ADHD, albeit with small effect sizes. Cortical analyses identified unique differences in each disorder, but also considerable overlap between the two, specifically in cortical thickness. Ongoing work is examining alternative research questions, such as brain laterality, prediction of case-control status, and anatomical heterogeneity. In brief, great strides have been made toward fulfilling the aims of the ENIGMA collaborations, while new ideas and follow-up analyses continue that include more imaging modalities (diffusion MRI and resting-state functional MRI), collaborations with other large databases, and samples with dual diagnoses., Martine Hoogman is supported by a personal Veni grant of the Netherlands Organization for Scientific Research (NWO, grant number 91619115). Odile A. van den Heuvel is supported by a personal VIDI grant of the Netherlands Organization for Scientific Research (NWO/ZonMw, number 91717306). This work has further benefited from grants for the NeuroIMAGE study which was supported by NIH Grant R01MH62873 (to Stephen V. Faraone), NWO Large Investment Grant 1750102007010 (to Jan Buitelaar), ZonMW grant 60‐60600‐97‐193, NWO grants 056‐13‐015 and 433‐09‐242, and matching grants from Radboud University Nijmegen Medical Center, University Medical Center Groningen and Accare, and Vrije Universiteit Amsterdam. This also included support from the European Community's Seventh Framework Programme (FP7/2007‐2013) under grant agreement number 278948 (TACTICS), 602805 (Aggressotype), 603016 (MATRICS), and 602450 (Imagemend), and the Innovation Medicine Initiative grants 115300 (EU‐AIMS) and 777394 (AIMS‐2‐TRIALS). Support was also received from the Dutch National Science Agenda for the NWA NeurolabNL project (grant 400 17 602). The first and senior authors would like to acknowledge the Cognomics Initiative, a joint initiative by researchers of the Donders Centre for Cognitive Neuroimaging, the Human Genetics and Cognitive Neuroscience departments of the Radboud University Medical Center, and the Max Planck Institute for Psycholinguistics in Nijmegen. The Cognomics Initiative has received support from the participating departments and centres and from external grants, that is, the Biobanking and Biomolecular Resources Research Infrastructure (Netherlands) (BBMRI‐NL), the Hersenstichting Nederland, the Netherlands Organization for Scientific Research (NWO), and the European Community's Seventh Framework Programme (FP7/2007–2013) under grant agreements n° 602450 (IMAGEMEND). In addition, the work was supported by a grant for the ENIGMA Consortium (grant number U54 EB020403) from the BD2K Initiative of a cross‐NIH partnership. The POND (Province of Ontario Neurodevelopmental Disorders) data collection was supported by the grant IDS‐I l‐02 (to Evdokia Anagnostou, Jason Lerch) from the Ontario Brain Institute, as well as CIHR support from grants CIHR‐106582, CIHR‐142379 (to Margot Taylor). Initial support for the ENIGMA ADHD and ASD working groups was provided by the U.S. National Institutes of Health Big Data to Knowledge Program (BD2K), under grant U54 EB020403. Joel T. Nigg is supported by an NIH grant R01 MH115357.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Cortical thickness across the lifespan: Data from 17,075 healthy individuals aged 3–90 years

  • Frangou, Sophia
  • Modabbernia, Amirhossein
  • Williams, Steven C. R.
  • Papachristou, Efstathios
  • Doucet, Gaelle E.
  • Agartz, Ingrid
  • Aghajani, Moji
  • Akudjedu, Theophilus N.
  • Albajes Eizagirre, Anton
  • Alnæs, Dag
  • Alpert, Kathryn I.
  • Jönsson, Erik G.
  • Brandeis, Daniel
  • Breier, Alan
  • Glahn, David C.
  • Brodaty, Henry
  • Hatton, Sean N.
  • Mataix-Cols, David
  • Holmes, Avram J.
  • Salvador, Raymond
  • Temmingh, Henk S.
  • Zanetti, Marcus V.
  • Haan, Lieuwe de
  • Brouwer, Rachel M.
  • Andreassen, Ole A.
  • Caseras, Xavier
  • Joska, John A.
  • Castellanos, Francisco X.
  • Cervenka, Simon
  • Chaim-Avancini, Tiffany M.
  • Paloyelis, Yannis
  • Koops, Sanne
  • Naaijen, Jilly
  • Wang, Lei
  • Hosten, Norbert
  • Ching, Christopher R. K.
  • Busatto, Geraldo F.
  • Grabe, Hans Jörgen
  • Conzelmann, Annette
  • Sachdev, Perminder S.
  • Zubicaray, Greig I.
  • Mcdonald, Colm
  • Braber, Anouk
  • Najt, Pablo
  • Dickie, Erin W.
  • Di Giorgio, Annabella
  • Satterthwaite, Theodore D.
  • Doan, Nhat Trung
  • Rinker, Daniel A.
  • Andreasen, Nancy C.
  • Lebedeva, Irina
  • Dørum, Erlend S.
  • Crone, Eveline A.
  • Hoogman, Martine
  • Trollor, Julian N.
  • Fatouros Bergman, Helena
  • Tamnes, Christian K.
  • Grimm, Oliver
  • Ortiz García Foz, Víctor
  • Groenewold, Nynke A.
  • Roffman, Joshua L.
  • Grotegerd, Dominik
  • Gruber, Oliver
  • Tordesillas Gutiérrez, Diana
  • Gruner, Patricia
  • Nakao, Tomohiro
  • Soriano Mas, Carles
  • Pauli, Paul
  • Lee, Won Hee
  • Gur, Rachel E.
  • Franke, Barbara
  • Lázaro García, Luisa
  • Wen, Wei
  • Heinz, Andreas
  • Walton, Esther
  • Howells, Fleur M.
  • Völzke, Henry
  • Sarró, Salvador
  • Hulshoff Pol, Hilleke E.
  • Stein, Dan J., 1962-
  • Huyser, Chaim
  • Jahanshad, Neda
  • Weber, Bernd
  • James, Anthony
  • Rosa, Pedro G. P.
  • Veer, Ilya M.
  • Saykin, Andrew J.
  • Buitelaar, Jan K.
  • McIntosh, Andrew M.
  • Jernigan, Terry L.
  • Hickie, Ian B.
  • Kalnin, Andrew
  • Bargalló Alabart, Núria
  • Kanai, Ryota
  • Andersson, Micael
  • Lesch, Klaus-Peter
  • Thompson, Paul M.
  • Tomyshev, Alexander S.
  • West, John D.
  • Lochner, Christine
  • Veltman, Dick J.
  • Machielsen, Marise W. J.
  • Maingault, Sophie
  • Banaschewski, Tobias
  • Martin, Nicholas G.
  • Strike, Lachlan T.
  • Yoncheva, Yulyia
  • Turner, Jessica A.
  • Crivello, Fabrice
  • Fouche, Jean Paul
  • Pergola, Giulio
  • Martínez Zalacaín, Ignacio
  • Koenders, Laura
  • McMahon, Katie L.
  • Voineskos, Aristotle
  • McPhilemy, Genevieve
  • Menchón Magriñá, José Manuel
  • Medland, Sarah E.
  • Calhoun, Vincent
  • Wassink, Thomas H.
  • Hibar, Derrek P.
  • Baumeister, Sarah
  • Meyer Lindenberg, Andreas
  • Mazoyer, Bernard
  • Serpa, Mauricio H.
  • Nordvik, Jan E.
  • Crespo-Facorro, Benedicto
  • Pomarol-Clotet, Edith
  • Ziegler, Georg C.
  • Portella, Maria J.
  • Potkin, Steven G.
  • Radua, Joaquim
  • Davey, Christopher
  • Asherson, Philip
  • Chubar, Victoria
  • Klyushnik, Tatyana P.
  • Whalley, Heather
  • Reif, Andreas
  • Oosterlaan, Jaap
  • Uhlmann, Anne
  • Sacchet, Matthew D.
  • Fisher, Simon E.
  • Schmaal, Lianne
  • Buckner, Randy L.
  • Schnell, Knut
  • Clark, Vincent P.
  • Schumann, Gunter
  • Sim, Kang
  • Fuentes Claramonte, Paola
  • Smoller, Jordan W.
  • Ehrlich, Stefan
  • Canales Rodríguez, Erick Jorge
  • Bertolino, Alessandro
  • Sommer, Iris
  • Sánchez Juan, Pascual
  • Westlye, Lars T.
  • Hohmann, Sarah
  • Swagerman, Suzanne C.
  • Heslenfeld, Dirk J.
  • Heuvel, Odile A.
  • Dale, Anders M.
  • Meer, Dennis
  • Erk, Susanne
  • Wee, Nic J. A.
  • Haren, Neeltje E. M.
  • Hoekstra, Pieter J.
  • Ent, Dennis
  • Conrod, Patricia
  • Gur, Ruben C.
  • Geus, Eco J. C.
  • Bonvino, Aurora
  • Erp, Theo G. M.
  • Thomopoulos, Sophia I.
  • Baur Streubel, Ramona
  • Kuntsi, Jonna
  • Walter, Henrik
  • Klein, Marieke
  • Wierenga, Lara M.
  • Kahn, Rene
  • Frodl, Thomas
  • Wittfeld, Katharina
  • Harrison, Ben J.
  • Wolf, Daniel H.
  • Worker, Amanda
  • Krämer, Bernd
  • Wright, Margaret J.
  • Espeseth, Thomas
  • Jiang, Jiyang
  • Gotlib, Ian H.
  • Nyberg, Lars
  • Cannon, Dara M.
  • Yang, Kun
  • Wang, Yang
  • Dima, Danai
  • Hartman, Catharine A.
  • Karolinska Schizophrenia Project (KaSP)
  • Boomsma, Dorret I.
  • Borgwardt, Stefan
  • Mcdonald, Brenna C.
  • Ho, Beng Choon
  • Lagopoulos, Jim
  • Bourque, Josiane
Delineating the association of age and cortical thickness in healthy individuals is critical given the association of cortical thickness with cognition and behavior. Previous research has shown that robust estimates of the association between age and brain morphometry require large-scale studies. In response, we used cross-sectional data from 17,075 individuals aged 3-90 years from the Enhancing Neuroimaging Genetics through Meta-Analysis (ENIGMA) Consortium to infer age-related changes in cortical thickness. We used fractional polynomial (FP) regression to quantify the association between age and cortical thickness, and we computed normalized growth centiles using the parametric Lambda, Mu, and Sigma method. Interindividual variability was estimated using meta-analysis and one-way analysis of variance. For most regions, their highest cortical thickness value was observed in childhood. Age and cortical thickness showed a negative association; the slope was steeper up to the third decade of life and more gradual thereafter; notable exceptions to this general pattern were entorhinal, temporopolar, and anterior cingulate cortices. Interindividual variability was largest in temporal and frontal regions across the lifespan. Age and its FP combinations explained up to 59% variance in cortical thickness. These results may form the basis of further investigation on normative deviation in cortical thickness and its significance for behavioral and cognitive outcomes.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Diminished modulation of preparatory sensorimotor mu rhythm predicts attention-deficit/hyperactivity disorder severity

  • ter Huurne, N.
  • Lozano-Soldevilla, D.
  • Onnink, M.
  • Kan, C.
  • Buitelaar, J.
  • Jensen, O.
The authors gratefully acknowledge funding from The Netherlands Organization for Scientific Research (NWO): a VICI grant (453–09–002) to O.J., and from Karakter Child and Adolescent Psychiatry to N.t.H. The work of J.B. for the current paper is supported by the European Community’s Seventh Framework Programme (FP7/2007–2013) under grant agreement no. 278948 (TACTICS) and from the European Community’s Horizon 2020 Programme (H2020/2014–2020) under grant agreements no. 643051 (MiND) and no. 642996 (BRAINVIEW)., Background: Attention-deficit/hyperactivity disorder (ADHD) is characterized by problems in regulating attention and in suppressing disruptive motor activity, i.e. hyperactivity and impulsivity. We recently found evidence that aberrant distribution of posterior α band oscillations (8–12 Hz) is associated with attentional problems in ADHD. The sensorimotor cortex also produces strong 8–12 Hz band oscillations, namely the μ rhythm, and is thought to have a similar inhibitory function. Here, we now investigate whether problems in distributing α band oscillations in ADHD generalize to the μ rhythm in the sensorimotor domain. Method: In a group of adult ADHD (n = 17) and healthy control subjects (n = 18; aged 21–40 years) oscillatory brain activity was recorded using magnetoencephalography during a visuo-spatial attention task. Subjects had to anticipate a target with unpredictable timing and respond by pressing a button. Results: Preparing a motor response, the ADHD group failed to increase hemispheric μ lateralization with relatively higher μ power in sensorimotor regions not engaged in the task, as the controls did (F1,33 = 8.70, p = 0.006). Moreover, the ADHD group pre-response μ lateralization not only correlated positively with accuracy (rs = 0.64, p = 0.0052) and negatively with intra-individual reaction time variability (rs = −0.52, p = 0.033), but it also correlated negatively with the score on an ADHD rating scale (rs = −0.53, p = 0.028). Conclusions: We suggest that ADHD is associated with an inability to sufficiently inhibit task-irrelevant sensorimotor areas by means of modulating μ oscillatory activity. This could explain disruptive motor activity in ADHD. These results provide further evidence that impaired modulation of α band oscillations is involved in the pathogenesis of ADHD., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

The gut-microbiome in adult Attention-deficit/hyperactivity disorder - A Meta-analysis

  • Jakobi, Babette
  • Vlaming, Priscilla
  • Mulder, Danique
  • Richarte, Vanesa
  • Ribases, Marta
  • Ramos-Quiroga, Josep Antoni
ADHD; Gut-microbiota, TDAH; Microbiota intestinal, TDAH; Microbiota intestinal, Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental condition that persists into adulthood in the majority of individuals. While the gut-microbiome seems to be relevant for ADHD, the few publications on gut-microbial alterations in ADHD are inconsistent, in the investigated phenotypes, sequencing method/region, preprocessing, statistical approaches, and findings. To identify gut-microbiome alterations in adult ADHD, robust across studies and statistical approaches, we harmonized bioinformatic pipelines and analyses of raw 16S rRNA sequencing data from four adult ADHD case-control studies (NADHD=312, NNoADHD=305). We investigated diversity and differential abundance of selected genera (logistic regression and ANOVA-like Differential Expression tool), corrected for age and sex, and meta-analyzed the study results. Converging results were investigated for association with hyperactive/impulsive and inattentive symptoms across all participants. Beta diversity was associated with ADHD diagnosis but showed significant heterogeneity between cohorts, despite harmonized analyses. Several genera were robustly associated with adult ADHD; e.g., Ruminococcus_torques_group (LogOdds=0.17, pfdr=4.42 × 10-2), which was more abundant in adults with ADHD, and Eubacterium_xylanophilum_group (LogOdds= -0.12, pfdr=6.9 × 10-3), which was less abundant in ADHD. Ruminococcus_torques_group was further associated with hyperactivity/impulsivity symptoms and Eisenbergiella with inattention and hyperactivity/impulsivity (pfdr<0.05). The literature points towards a role of these genera in inflammatory processes. Irreproducible results in the field of gut-microbiota research, due to between study heterogeneity and small sample sizes, stress the need for meta-analytic approaches and large sample sizes. While we robustly identified genera associated with adult ADHD, that might overall be considered beneficial or risk-conferring, functional studies are needed to shed light on these properties., This project was supported by grants from National Institutes of Health (grant R01MH62873 to SV Faraone) for initial sample recruitment, and from NWO Large Investment (grant 1750102007010 to JK Buitelaar), NWO Brain & Cognition (grant 433-09-242 to JK Buitelaar), and grants from Radboud University Medical Center, University Medical Center Groningen, Accare, and VU University Amsterdam for subsequent assessment waves. NeuroIMAGE also received funding from the European Community's Seventh Framework Programme (FP7/2007 – 2013) under grant agreements n° 602805 (Aggressotype), n° 278948 (TACTICS), and n° 602450 (IMAGEMEND), and from the European Community's Horizon 2020 Programme (H2020/2014 – 2020) under grant agreements n° 643051 (MiND), n° 667302 (CoCA), and n° 728018 (Eat2beNICE). IMpACT: We acknowledge funding from the Netherlands Organization for Scientific Research (NWO), i.e. the Veni Innovation Program (grant 016-196-115 to MH) and the Vici Innovation Program (grant 016–130-669 to BF). The work was also supported by the European College of Neuropsychopharmacology (ECNP) Network “ADHD Across the Lifespan”. BJ and BF were also supported by funding from the European Community's Horizon 2020 Programme (H2020/2014 – 2020) under grant agreement n 847879 (PRIME).
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Identification of ADHD risk genes in extended pedigrees by combining linkage analysis and whole-exome sequencing

  • Corominas Galbany, Jordi|||0000-0003-1736-1278
  • Klein, Marieke|||0000-0001-8784-5679
  • Zayats, Tetyana
  • Rivero, Olga|||0000-0002-2664-4053
  • Ziegler, Georg C.|||0000-0001-9411-3169
  • Pauper, Marc
  • Neveling, Kornelia
  • Poelmans, Geert
  • Jansch, Charline
  • Svirin, Evgeniy|||0000-0003-3501-574X
  • Geissler, Julia
  • Weber, Heike|||0000-0002-9421-1292
  • Reif, Andreas|||0000-0002-0992-634X
  • Arias-Vásquez, Alejandro|||0000-0002-4786-0169
  • Galesloot, Tessel E.
  • Kiemeney, Lambertus A. L. M.
  • Buitelaar, Jan|||0000-0001-8288-7757
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Cormand, Bru|||0000-0001-5318-4382
  • Ribasés Haro, Marta|||0000-0003-1039-1116
  • Hveem, Kristian|||0000-0001-8157-9744
  • Gabrielsen, Maiken Elvestad
  • Hoffmann, Per|||0000-0002-6573-983X
  • Cichon, Sven|||0000-0002-9475-086X
  • Haavik, Jan|||0000-0001-7865-2808
  • Johansson, Stefan E.|||0000-0002-2298-7008
  • Jacob, Christian P.
  • Romanos, Marcel
  • Franke, Barbara|||0000-0003-4375-6572
  • Lesch, Klaus-Peter|||0000-0001-8348-153X
Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder with a complex genetic background, hampering identification of underlying genetic risk factors. We hypothesized that combining linkage analysis and whole-exome sequencing (WES) in multi-generation pedigrees with multiple affected individuals can point toward novel ADHD genes. Three families with multiple ADHD-affected members (N = 70) and apparent dominant inheritance pattern were included in this study. Genotyping was performed in 37 family members, and WES was additionally carried out in 10 of those. Linkage analysis was performed using multi-point analysis in Superlink Online SNP 1.1. From prioritized linkage regions with a LOD score ≥ 2, a total of 24 genes harboring rare variants were selected. Those genes were taken forward and were jointly analyzed in gene-set analyses of exome-chip data using the MAGMA software in an independent sample of patients with persistent ADHD and healthy controls (N = 9365). The gene-set including all 24 genes together, and particularly the gene-set from one of the three families (12 genes), were significantly associated with persistent ADHD in this sample. Among the latter, gene-wide analysis for the AAED1 gene reached significance. A rare variant (rs151326868) within AAED1 segregated with ADHD in one of the families. The analytic strategy followed here is an effective approach for identifying novel ADHD risk genes. Additionally, this study suggests that both rare and more frequent variants in multiple genes act together in contributing to ADHD risk, even in individual multi-case families.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Cortical thickness across the lifespan, Data from 17,075 healthy individuals aged 3-90 years

  • Frangou, Sophia|||0000-0002-3210-6470
  • Modabbernia, Amirhossein
  • Williams, Steven C. R.
  • Papachristou, Efstathios
  • Doucet, Gaelle E.|||0000-0003-4120-0474
  • Agartz, Ingrid|||0000-0002-9839-5391
  • Aghajani, Moji|||0000-0003-2040-4881
  • Akudjedu, Theophilus|||0000-0003-2423-6897
  • Albajes-Eizagirre, Anton
  • Alnæs, Dag
  • Alpert, Kathryn I.
  • Andersson, Micael
  • Andreasen, Nancy C.
  • Andreassen, Ole A.|||0000-0002-4461-3568
  • Asherson, Philip|||0000-0003-2667-2254
  • Banaschewski, Tobias
  • Bargalló, Núria|||0000-0001-6284-5402
  • Baumeister, Sarah
  • Baur-Streubel, Ramona
  • Bertolino, Alessandro
  • Bonvino, Aurora
  • Boomsma, Dorret I.|||0000-0002-7099-7972
  • Borgwardt, Stefan
  • Bourque, Josiane
  • Brandeis, Daniel
  • Breier, Alan
  • Brodaty, Henry|||0000-0001-9487-6617
  • Brouwer, Rachel M.|||0000-0002-7466-1544
  • Buitelaar, Jan|||0000-0001-8288-7757
  • Busatto, Geraldo F.
  • Buckner, Randy|||0000-0001-6422-8037
  • Calhoun, Vince
  • Canales-Rodriguez, Erick Jorge|||0000-0001-6421-2633
  • Cannon, Dara M.
  • Caseras, Xavier|||0000-0002-8490-6891
  • Castellanos, Francisco X.|||0000-0001-9192-9437
  • Cervenka, Simon
  • Chaim-Avancini, Tiffany M.
  • Ching, Christopher R. K.|||0000-0003-2921-3408
  • Chubar, Victoria
  • Clark, Vincent P.|||0000-0002-9151-2102
  • Conrod, Patricia
  • Conzelmann, Annette
  • Crespo-Facorro, Benedicto|||0000-0003-0033-7132
  • Crivello, Fabrice|||0000-0001-6950-984X
  • Crone, Eveline A.
  • Dale, Anders M.
  • Dannlowski, Udo|||0000-0002-0623-3759
  • Davey, Christopher|||0000-0003-1431-3852
  • de Geus, Eco J. C.|||0000-0001-6022-2666
  • Haan, Lieuwe de, 1960-|||0000-0002-3820-7926
  • de Zubicaray, Greig|||0000-0003-4506-0579
  • den Braber, A.
  • Dickie, Erin W.
  • Di Giorgio, Annabella
  • Doan, Nhat Trung
  • Dørum, Erlend S.
  • Ehrlich, Stefan|||0000-0003-2132-4445
  • Erk, Susanne
  • Espeseth, Thomas
  • Fatouros-Bergman, Helena|||0000-0003-4565-5839
  • Fisher, Simon E.|||0000-0002-3132-1996
  • Fouche, Jean-Paul|||0000-0002-0830-2324
  • Franke, Barbara|||0000-0003-4375-6572
  • Frodl, Thomas|||0000-0002-8113-6959
  • Fuentes-Claramonte, Paola|||0000-0002-1428-7976
  • Glahn, David C.|||0000-0002-4749-6977
  • Gotlib, Ian H.|||0000-0002-3622-3199
  • Grabe, Hans-Jörgen
  • Grimm, Oliver|||0000-0002-0767-0301
  • Groenewold, Nynke A.|||0000-0002-0865-8427
  • Grotegerd, Dominik
  • Gruber, Oliver
  • Gruner, Patricia
  • Gur, Raquel E.
  • Gur, Ruben C.
  • Hahn, Tim|||0000-0002-8929-4134
  • Harrison, Ben J.
  • Hartman, Catharina A.
  • Hatton, Sean N.|||0000-0002-9149-8726
  • Heinz, Andreas
  • Heslenfeld, Dirk J.
  • Hibar, Derrek P.
  • Hickie, Ian B.|||0000-0001-8832-9895
  • Ho, Beng-Choon|||0000-0003-3976-1555
  • Hoekstra, Pieter J.
  • Hohmann, Sarah
  • Holmes, Avram J.
  • Hoogman, Martine|||0000-0002-1261-7628
  • Hosten, Norbert
  • Howells, Fleur M.|||0000-0001-9759-2556
  • Hulshoff Pol, Hilleke E.|||0000-0002-2038-5281
  • Huyser, Chaim|||0000-0001-8757-3124
  • Jahanshad, Neda|||0000-0003-4401-8950
  • James, Anthony|||0000-0002-2742-8328
  • Jernigan, Terry L.
  • Jiang, Jiyang|||0000-0002-2147-6302
  • Jönsson, Erik G.|||0000-0001-8368-6332
  • Joska, John A.
  • Kahn, Rene
  • Kalnin, Andrew
  • Kanai, Ryota
  • Klein, Marieke|||0000-0001-8784-5679
  • Klyushnik, Tatyana P.
  • Koenders, Laura
  • Koops, Sanne
  • Krämer, Bernd|||0000-0002-1145-9103
  • Kuntsi, Jonna|||0000-0002-0113-8162
  • Lagopoulos, Jim
  • Lázaro, Luisa|||0000-0002-8425-5750
  • Lebedeva, Irina
  • Lee, Won Hee
  • Lesch, Klaus-Peter|||0000-0001-8348-153X
  • Lochner, Christine|||0000-0002-4766-3704
  • Machielsen, Marise W. J.
  • Maingault, Sophie
  • Martin, Nicholas G.|||0000-0003-4069-8020
  • Martínez-Zalacaín, Ignacio|||0000-0002-4036-0284
  • Mataix-Cols, David|||0000-0002-4545-0924
  • Mazoyer, Bernard|||0000-0003-0970-2837
  • McDonald, Colm|||0000-0003-1661-5192
  • McDonald, Brenna C.
  • McIntosh, Andrew M.|||0000-0002-0198-4588
  • McMahon, Katie L.
  • McPhilemy, Genevieve
  • Meinert, Susanne|||0000-0003-2177-7161
  • Menchón Magriñá, José Manuel|||0000-0002-6231-6524
  • Medland, Sarah Elizabeth|||0000-0003-1382-380X
  • Meyer-Lindenberg, Andreas|||0000-0001-5619-1123
  • Naaijen, Jilly
  • Najt, Pablo
  • Nakao, Tomohiro
  • Nordvik, Jan E.
  • Nyberg, Lars
  • Oosterlaan, Jaap
  • de la Foz, Víctor Ortiz-García
  • Paloyelis, Yannis
  • Pauli, Paul
  • Pergola, Giulio
  • Pomarol-Clotet, Edith|||0000-0002-8159-8563
  • Portella Moll, Maria J., 1975-|||0000-0002-2007-9516
  • Potkin, Steven G.
  • Radua, Joaquim|||0000-0003-1240-5438
  • Reif, Andreas|||0000-0002-0992-634X
  • Rinker, Daniel A.
  • Roffman, Joshua L.
  • Rosa, Pedro G. P.
  • Sacchet, Matthew D.
  • Sachdev, Perminder S.|||0000-0002-9595-3220
  • Salvador, Raymond|||0000-0001-5557-1562
  • Sánchez-Juan, Pascual|||0000-0002-6081-8037
  • Sarró, Salvador|||0000-0003-1835-2189
  • Satterthwaite, Theodore D.|||0000-0001-7072-9399
  • Saykin, Andrew J.
  • Serpa, Mauricio H.
  • Schmaal, Lianne|||0000-0001-9822-048X
  • Schnell, Knut
  • Schumann, Gunter
  • Sim, Kang|||0000-0003-3209-9626
  • Smoller, Jordan W.|||0000-0002-0381-6334
  • Sommer, Iris
  • Soriano-Mas, Carles|||0000-0003-4574-6597
  • Stein, Dan J.|||0000-0001-7218-7810
  • Strike, Lachlan|||0000-0003-2885-5898
  • Swagerman, Suzanne C.
  • Tamnes, Christian K.
  • Temmingh, Henk S.
  • Thomopoulos, Sophia I.|||0000-0002-0046-4070
  • Tomyshev, Alexander S.
  • Tordesillas-Gutiérrez, Diana
  • Trollor, Julian|||0000-0002-7685-2977
  • Turner, Jessica A.
  • Uhlmann, Anne|||0000-0002-1753-7811
  • van den Heuvel, Odile A.|||0000-0002-9804-7653
  • van den Meer, Dennis
  • Van der Wee, Nic J. A.
  • van Haren, Neeltje E. M.
  • van 't Ent, Dennis
  • van Erp, Theo G. M.|||0000-0002-2465-2797
  • Veer, Ilya M.
  • Veltman, Dick J.
  • Voineskos, Aristotle|||0000-0003-0156-0395
  • Völzke, Henry|||0000-0001-7003-399X
  • Walter, Henrik|||0000-0002-9403-6121
  • Walton, Esther|||0000-0002-0935-2200
  • Wang, Lei
  • Wang, Yang
  • Wassink, Thomas H.
  • Weber, Bernd
  • Wen, Wei|||0000-0003-2753-3870
  • West, John D.
  • Westlye, Lars T.|||0000-0001-8644-956X
  • Whalley, Heather|||0000-0002-4505-8869
  • Wierenga, Lara M.|||0000-0001-9362-563X
  • Wittfeld, Katharina|||0000-0003-4383-5043
  • Wolf, Daniel H.
  • Worker, Amanda
  • Wright, Margaret J.|||0000-0001-7133-4970
  • Yang, Kun
  • Yoncheva, Yuliya N.|||0000-0001-6495-7504
  • Zanetti, Marcus Vinicius|||0000-0001-7132-8933
  • Ziegler, Georg C.|||0000-0001-9411-3169
  • Thompson, Paul M.|||0000-0002-4720-8867
  • Dima, Danai|||0000-0002-2598-0952
Delineating the association of age and cortical thickness in healthy individuals is critical given the association of cortical thickness with cognition and behavior. Previous research has shown that robust estimates of the association between age and brain morphometry require large-scale studies. In response, we used cross-sectional data from 17,075 individuals aged 3-90 years from the Enhancing Neuroimaging Genetics through Meta-Analysis (ENIGMA) Consortium to infer age-related changes in cortical thickness. We used fractional polynomial (FP) regression to quantify the association between age and cortical thickness, and we computed normalized growth centiles using the parametric Lambda, Mu, and Sigma method. Interindividual variability was estimated using meta-analysis and one-way analysis of variance. For most regions, their highest cortical thickness value was observed in childhood. Age and cortical thickness showed a negative association; the slope was steeper up to the third decade of life and more gradual thereafter; notable exceptions to this general pattern were entorhinal, temporopolar, and anterior cingulate cortices. Interindividual variability was largest in temporal and frontal regions across the lifespan. Age and its FP combinations explained up to 59% variance in cortical thickness. These results may form the basis of further investigation on normative deviation in cortical thickness and its significance for behavioral and cognitive outcomes. We used cross-sectional data from 17,075 individuals aged 3-90 years from the Enhancing Neuroimaging Genetics through Meta-Analysis (ENIGMA) Consortium to infer age-related changes in cortical thickness.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

The gut-microbiome in adult Attention-deficit/hyperactivity disorder - A Meta-analysis

  • Jakobi, Babette
  • Vlaming, Priscilla
  • Mulder, Danique
  • Richarte, Vanesa
  • Ribases, Marta
  • Ramos-Quiroga, Josep Antoni
ADHD; Gut-microbiota, TDAH; Microbiota intestinal, TDAH; Microbiota intestinal, Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental condition that persists into adulthood in the majority of individuals. While the gut-microbiome seems to be relevant for ADHD, the few publications on gut-microbial alterations in ADHD are inconsistent, in the investigated phenotypes, sequencing method/region, preprocessing, statistical approaches, and findings. To identify gut-microbiome alterations in adult ADHD, robust across studies and statistical approaches, we harmonized bioinformatic pipelines and analyses of raw 16S rRNA sequencing data from four adult ADHD case-control studies (NADHD=312, NNoADHD=305). We investigated diversity and differential abundance of selected genera (logistic regression and ANOVA-like Differential Expression tool), corrected for age and sex, and meta-analyzed the study results. Converging results were investigated for association with hyperactive/impulsive and inattentive symptoms across all participants. Beta diversity was associated with ADHD diagnosis but showed significant heterogeneity between cohorts, despite harmonized analyses. Several genera were robustly associated with adult ADHD; e.g., Ruminococcus_torques_group (LogOdds=0.17, pfdr=4.42 × 10-2), which was more abundant in adults with ADHD, and Eubacterium_xylanophilum_group (LogOdds= -0.12, pfdr=6.9 × 10-3), which was less abundant in ADHD. Ruminococcus_torques_group was further associated with hyperactivity/impulsivity symptoms and Eisenbergiella with inattention and hyperactivity/impulsivity (pfdr<0.05). The literature points towards a role of these genera in inflammatory processes. Irreproducible results in the field of gut-microbiota research, due to between study heterogeneity and small sample sizes, stress the need for meta-analytic approaches and large sample sizes. While we robustly identified genera associated with adult ADHD, that might overall be considered beneficial or risk-conferring, functional studies are needed to shed light on these properties., This project was supported by grants from National Institutes of Health (grant R01MH62873 to SV Faraone) for initial sample recruitment, and from NWO Large Investment (grant 1750102007010 to JK Buitelaar), NWO Brain & Cognition (grant 433-09-242 to JK Buitelaar), and grants from Radboud University Medical Center, University Medical Center Groningen, Accare, and VU University Amsterdam for subsequent assessment waves. NeuroIMAGE also received funding from the European Community's Seventh Framework Programme (FP7/2007 – 2013) under grant agreements n° 602805 (Aggressotype), n° 278948 (TACTICS), and n° 602450 (IMAGEMEND), and from the European Community's Horizon 2020 Programme (H2020/2014 – 2020) under grant agreements n° 643051 (MiND), n° 667302 (CoCA), and n° 728018 (Eat2beNICE). IMpACT: We acknowledge funding from the Netherlands Organization for Scientific Research (NWO), i.e. the Veni Innovation Program (grant 016-196-115 to MH) and the Vici Innovation Program (grant 016–130-669 to BF). The work was also supported by the European College of Neuropsychopharmacology (ECNP) Network “ADHD Across the Lifespan”. BJ and BF were also supported by funding from the European Community's Horizon 2020 Programme (H2020/2014 – 2020) under grant agreement n 847879 (PRIME).